{"study_id": 32601, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether policosanol, alone or combined with atorvastatin, affects serum PCSK9 levels compared to statin treatment alone.", "results_summary": "Policosanol combined with atorvastatin attenuated the statin-induced increase in PCSK9 levels (17.4% vs. 39.4% with statin alone). Policosanol alone showed a trend toward decreasing PCSK9 levels, though not statistically significant.", "population_specificity": "26 patients with atherosclerosis (Protocol I) and 15 healthy volunteers (Protocol II).", "effective_dosage": "20 mg/d policosanol, 20 mg/d atorvastatin (Protocol I); 20 mg/d policosanol (Protocol II).", "study_duration": "8 weeks (Protocol I), 12 weeks (Protocol II).", "interactions": "Atorvastatin (statin) interaction noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:02.551342+00:00"}
{"study_id": 32604, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the cholesterol-lowering effects of low-dose policosanol (PC) and its combination with glucomannan (GM) in hypercholesterolemic children.", "results_summary": "The study found that GM combined with low-dose PC reduced total cholesterol (CholT) and LDL without affecting HDL, triglycerides, or fasting blood glucose. The combination showed significant lipid-lowering effects compared to placebo (resistant starch).", "population_specificity": "120 hypercholesterolemic children (60 male, 60 female, aged 3-16 years, median 9.6 years).", "effective_dosage": "Low-dose (specific amount not stated in abstract).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:04.579978+00:00"}
{"study_id": 32603, "supplement_id": 1458, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "To evaluate the effects and safety of policosanol combined with simvastatin on serum lipids and sex hormones in male patients with hyperlipidemia.", "results_summary": "Policosanol combined with simvastatin significantly reduced TC and LDL-C more than simvastatin alone, without increasing adverse effects or altering sex hormone levels. Adverse reactions were mild and well-tolerated.", "population_specificity": "Male patients with hyperlipidemia (n=120).", "effective_dosage": "20 mg/d policosanol + 40 mg/d simvastatin.", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:06.672025+00:00"}
{"study_id": 32607, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy and safety of modified-policosanol (MP) on major lipoproteins in hyperlipidemic subjects, both as monotherapy and in combination with statin therapy.", "results_summary": "The study found that MP did not significantly affect major lipoproteins, whether used alone or with statins, but it was well-tolerated with no major adverse events reported.", "population_specificity": "Hyperlipidemic subjects (some on chronic statin therapy, others not).", "effective_dosage": "20 mg daily", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:08.979077+00:00"}
{"study_id": 32606, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy, safety, and tolerability of a nutraceutical combination containing Policosanol in elderly hypercholesterolemic patients previously intolerant to statins.", "results_summary": "The study found a statistically significant reduction in total cholesterol (-20%) and LDL-C (-31%) with the nutraceutical treatment, which included Policosanol. The treatment was safe and well-tolerated, with no significant adverse events or changes in safety parameters.", "population_specificity": "Elderly hypercholesterolemic patients (>75 years) who were statin-intolerant and refused other pharmaceutical treatments.", "effective_dosage": "10 mg Policosanol (as part of a combined nutraceutical pill taken once daily).", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:09.273710+00:00"}
{"study_id": 32605, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of policosanol on serum lipid levels and heme oxygenase-1 (HO-1) in patients with hyperlipidemia, assessing its lipid-lowering and anti-inflammatory properties.", "results_summary": "Policosanol significantly reduced total cholesterol (TC), LDL-C, HO-1, and hs-CRP levels in hyperlipidemia patients after 16 weeks, with no changes in TG or HDL-C. No adverse events were reported, and safety profiles were similar between the treatment and placebo groups.", "population_specificity": "72 patients with hyperlipidemia (36 in treatment group, 36 in placebo group).", "effective_dosage": "20 mg/d (policosanol), two tablets/d (placebo).", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:09.413893+00:00"}
{"study_id": 32608, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 10, "quality_score": 85, "study_goal": "To assess the feasibility of policosanol in normalizing dyslipidemic profiles in medically underserved HIV-infected individuals.", "results_summary": "Policosanol supplementation did not normalize any dyslipidemic parameters but was well tolerated with no adverse effects on HIV disease progression.", "population_specificity": "Medically underserved HIV-infected individuals (91% black) with lipid abnormalities.", "effective_dosage": "20 mg/day", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:09.662904+00:00"}
{"study_id": 32587, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy and safety of policosanol, fenofibrate, and their combination in lowering LDL-C and improving lipid profiles, arterial stiffness, and quality of life in elderly patients with mixed dyslipidemia.", "results_summary": "Policosanol significantly reduced LDL-C, non-HDL-C, and TC after 24 weeks, and its combination with fenofibrate showed greater improvements in lipid parameters. It also improved arterial stiffness and quality of life, with no serious adverse events reported.", "population_specificity": "Elderly patients (aged \u226560 years) with mixed dyslipidemia.", "effective_dosage": "20 mg/day policosanol.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:09.846582+00:00"}
{"study_id": 32609, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the mechanism by which policosanol lowers blood cholesterol levels, focusing on its effects on AMP-kinase and HMG-CoA reductase phosphorylation.", "results_summary": "Policosanol significantly increased the phosphorylation of AMP-kinase and HMG-CoA reductase in hepatoma cells and mouse liver, suggesting a potential mechanism for cholesterol reduction. Metabolism of policosanol to activated fatty acids was found necessary for this effect, likely via increased cellular AMP levels and peroxisomal \u03b2-oxidation.", "population_specificity": "Hepatoma cells and mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:11.097342+00:00"}
{"study_id": 32610, "supplement_id": 1458, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine whether policosanol interacts with warfarin by affecting its pharmacokinetics, pharmacodynamics, or platelet activity in healthy subjects.", "results_summary": "Policosanol did not significantly affect warfarin enantiomer pharmacokinetics, warfarin response (INR), or platelet aggregation after two weeks of pre-treatment. No clinically significant interactions were observed.", "population_specificity": "Healthy male subjects (n=12) of known CYP2C9 and VKORC1 genotype.", "effective_dosage": "Recommended doses (specific amount not stated in abstract).", "study_duration": "2 weeks of pre-treatment.", "interactions": "None mentioned with warfarin or platelet activity.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:14.359725+00:00"}
{"study_id": 32611, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of sugar cane policosanols (SCP) on cholesterol kinetics, specifically synthesis and absorption, in hypercholesterolemic individuals.", "results_summary": "The study found no significant changes in LDL cholesterol levels, cholesterol absorption, or fractional cholesterol synthesis rates between the SCP and placebo groups, contradicting previous research on policosanols' efficacy.", "population_specificity": "Otherwise healthy hypercholesterolemic subjects (n=21).", "effective_dosage": "10 mg/day incorporated in margarine as an evening snack.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:15.019016+00:00"}
{"study_id": 32612, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of policosanol (10 mg/d) and aspirin (100 mg/d) over 10 weeks on walking distances in patients with intermittent claudication.", "results_summary": "Policosanol significantly increased initial and absolute claudication distances, while aspirin had no effect. Policosanol also improved lipid profiles (lowered LDL and total cholesterol, raised HDL), unlike aspirin.", "population_specificity": "Patients with intermittent claudication (n=39).", "effective_dosage": "10 mg/d policosanol.", "study_duration": "10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:17.773827+00:00"}
{"study_id": 32616, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 10, "quality_score": 80, "study_goal": "The researchers aimed to determine whether sugar cane-derived policosanol effectively lowers LDL cholesterol and improves lipid profiles in healthy adults with mild hypercholesterolemia.", "results_summary": "The study found no significant differences in LDL cholesterol or other lipid measures between the policosanol and placebo groups after 8 weeks. Policosanol was well tolerated with no notable adverse events.", "population_specificity": "Healthy adults with mild hypercholesterolemia (n=40).", "effective_dosage": "20 mg once daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:18.054227+00:00"}
{"study_id": 32614, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 10, "quality_score": 85, "study_goal": "The researchers aimed to determine the lipoprotein-lowering effects of Cuban sugar cane-derived policosanol in subjects with primary hypercholesterolemia.", "results_summary": "The study found that policosanol at 20 mg daily for 8 weeks did not significantly change total cholesterol, HDL-cholesterol, LDL-cholesterol, or triglyceride levels compared to placebo. No lipid-lowering effects were observed.", "population_specificity": "Primary hypercholesterolemic subjects (n=68, with 63 completing the study).", "effective_dosage": "20 mg daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:18.286610+00:00"}
{"study_id": 32613, "supplement_id": 1458, "safety_score": "85", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of rice policosanol (10 mg/day) on blood coagulation factors in hypercholesterolemic patients.", "results_summary": "Rice policosanol treatment did not significantly alter plasma fibrinogen or coagulation factors VII, VIII, XII, and XIII. The study found no meaningful impact on blood coagulation.", "population_specificity": "66 hypercholesterolemic patients (both sexes, aged 20-78 years).", "effective_dosage": "10 mg once daily with the evening meal.", "study_duration": "8 weeks per treatment phase (crossover design, total 16 weeks including placebo).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:19.710598+00:00"}
{"study_id": 32617, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 10, "quality_score": 85, "study_goal": "The researchers aimed to determine the lipid-lowering efficacy of policosanol as monotherapy and its potential additive or synergistic effects when combined with atorvastatin.", "results_summary": "Policosanol (20 mg/d) did not significantly change lipid levels compared to baseline or placebo, nor did it enhance the lipid-lowering effects of atorvastatin. It was found to be safe with no adverse effects on liver enzymes or creatinine phosphokinase levels.", "population_specificity": "Patients with LDL-C levels between 140-189 mg/dL.", "effective_dosage": "20 mg daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:20.266032+00:00"}
{"study_id": 32615, "supplement_id": 1458, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia due to type 2 diabetes.", "results_summary": "Policosanol significantly reduced LDL-C (25.7%) and TC (18.2%), increased HDL-C (11.1%), and inhibited platelet aggregation, though it was less effective than atorvastatin in lowering LDL-C and TC. Both treatments were well tolerated, with policosanol showing no significant safety concerns.", "population_specificity": "Patients with type 2 diabetes (fasting glucose \u22647 mmol/L, HbA1c <8.5%) and high LDL-C levels (\u22653.0 mmol/L).", "effective_dosage": "10 mg/day, taken once daily with the evening meal.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:21.557330+00:00"}
{"study_id": 32619, "supplement_id": 1458, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the mechanism by which policosanol and its principal components inhibit cholesterol synthesis in cultured rat hepatoma cells, focusing on HMG-CoA reductase activity and AMP-kinase phosphorylation.", "results_summary": "Policosanol and triacontanol significantly inhibited cholesterol synthesis by suppressing HMG-CoA reductase activity, likely through AMP-kinase activation, without causing cellular toxicity. Other policosanol components showed smaller, statistically insignificant effects.", "population_specificity": "Cultured rat hepatoma cells", "effective_dosage": "Pharmacological concentrations (<5 \u00b5g/ml)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:23.421829+00:00"}
{"study_id": 32618, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects of policosanol (20 mg/day) on neurological recovery and recurrent vascular events in patients with ischemic stroke treated with antiplatelets and vitamins.", "results_summary": "Policosanol improved neurological scores, reduced recurrent vascular events (only 2% suffered a new stroke), and persistently lowered serum total cholesterol, correlating with neurological improvement. The treatment was well tolerated with no deaths reported.", "population_specificity": "Patients with ischemic stroke treated with aspirin and vitamins.", "effective_dosage": "20 mg/day", "study_duration": "5 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:23.910301+00:00"}
{"study_id": 32622, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of policosanol (Octa-60) on lipid profiles in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects.", "results_summary": "The study found no significant differences in total cholesterol and LDL-cholesterol levels between policosanol and placebo groups, indicating policosanol had no significant effect on serum lipid levels in these patients. Small reductions in cholesterol were observed but were not statistically different from placebo.", "population_specificity": "Hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects.", "effective_dosage": "20 mg/d", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:27.167533+00:00"}
{"study_id": 32620, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 10, "quality_score": 85, "study_goal": "To determine the lipoprotein-lowering effects of Cuban sugar cane-derived policosanol and establish dose-dependency up to 80 mg/d in patients with hypercholesterolemia or combined hyperlipidemia.", "results_summary": "Policosanol did not significantly reduce LDL-C levels or other lipid measures compared to placebo. No dose-dependent effects were observed, and the supplement was well-tolerated without serious adverse events.", "population_specificity": "Patients with hypercholesterolemia or combined hyperlipidemia, with baseline LDL-C levels \u2265150 mg/dL and varying cardiovascular risk factors.", "effective_dosage": "10, 20, 40, or 80 mg/d", "study_duration": "12-week treatment phase", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:28.874643+00:00"}
{"study_id": 32623, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to investigate the antilipemic efficacy and tolerability of policosanol in patients with moderate hypercholesterolemia.", "results_summary": "Policosanol significantly reduced plasma total cholesterol and increased apoprotein A I but did not affect triglycerides, HDL-C, LDL-C, or other lipid parameters. It was well tolerated with no adverse effects on safety parameters or clinical adverse reactions.", "population_specificity": "67 patients of both sexes aged 20-78 with moderate hypercholesterolemia.", "effective_dosage": "10 mg capsules once daily with the evening meal.", "study_duration": "8 weeks per treatment phase (16 weeks total with crossover).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:29.079316+00:00"}
{"study_id": 32621, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether combining policosanol with omega-3 fatty acids (\u03a93FA) enhances inhibition of platelet aggregation and improves lipid profiles in hypercholesterolemic patients compared to \u03a93FA alone.", "results_summary": "The combination of policosanol and \u03a93FA significantly inhibited platelet aggregation to arachidonic acid and collagen, reduced LDL-C and TC levels, and increased HDL-C levels, with no significant changes in bleeding time or triglyceride levels. The treatment was well tolerated with minimal adverse effects.", "population_specificity": "Outpatients aged 20-75 with hypercholesterolemia (serum total cholesterol \u22655 and <6 mmol/L) and some atherosclerotic risk factors.", "effective_dosage": "Policosanol 10 mg/day + \u03a93FA 1 g/day, taken orally with the evening meal.", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:29.267263+00:00"}
{"study_id": 32624, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "To investigate whether combined therapy with omega-3 fatty acids and policosanol offers benefits compared to omega-3 fatty acids alone in improving the lipid profile of patients with type II hypercholesterolaemia.", "results_summary": "Policosanol at 5 mg/day and 10 mg/day significantly reduced LDL-C, TC, and increased HDL-C, while maintaining the TG reduction from omega-3 FA monotherapy. The combination was well tolerated with minimal adverse effects.", "population_specificity": "90 patients with type II hypercholesterolaemia.", "effective_dosage": "5 mg/day or 10 mg/day policosanol, combined with 2 g/day omega-3 FA.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:30.389961+00:00"}
{"study_id": 32626, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combined therapy with policosanol and omega-3 fatty acids would offer greater benefits on serum lipid profile and platelet aggregation compared to either treatment alone in rabbits.", "results_summary": "Policosanol significantly lowered LDL-C and TC while increasing HDL-C, but did not affect TG levels. Combined therapy with policosanol and omega-3 FA achieved greater reductions in LDL-C and TG, and better inhibition of platelet aggregation than either treatment alone.", "population_specificity": "Male rabbits (n = 9 per group).", "effective_dosage": "Policosanol 5 mg/kg and omega-3 FA 250 mg/kg, orally administered.", "study_duration": "60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:33.339601+00:00"}
{"study_id": 32627, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 95, "quality_score": 85, "study_goal": "To compare the efficacy and safety of policosanol versus plant sterols and stanols in reducing LDL cholesterol levels in patients with coronary heart disease.", "results_summary": "Policosanol (12 mg/day) reduced LDL levels by 23.7% versus placebo, significantly outperforming plant sterols and stanols. It also improved total cholesterol, HDL, and triglyceride levels more favorably and had a low withdrawal rate due to adverse effects (0.86%).", "population_specificity": "4596 patients with coronary heart disease from 52 studies.", "effective_dosage": "12 mg/day (range 5-40 mg/day).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:33.407569+00:00"}
{"study_id": 32628, "supplement_id": 1458, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine if policosanol reinforces the antihypertensive effects of beta-blockers and whether this combination affects safety indicators or induces adverse events in older hypercholesterolemic patients.", "results_summary": "Policosanol significantly reduced LDL-C, TC, and TG while increasing HDL-C, with sustained effects over 3 years. It was well tolerated, with fewer adverse events and serious adverse events compared to placebo, and additionally reduced blood pressure.", "population_specificity": "Older hypercholesterolemic patients taking beta-blockers (205 participants).", "effective_dosage": "5 mg/day", "study_duration": "3 years", "interactions": "Pharmacodynamic interaction with beta-blockers (reinforces antihypertensive effects). No significant drug-to-drug interactions with cytochrome P450-metabolized drugs.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:36.964256+00:00"}
{"study_id": 32625, "supplement_id": 1458, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the tolerability of policosanol in elderly patients by monitoring adverse events in routine clinical practice.", "results_summary": "The study found that policosanol had very good long-term tolerability in elderly patients at high vascular risk, with a low incidence of adverse events (1.4% serious AEs, 0.6% hospitalizations, and 2.7% moderate/mild AEs). The results were consistent with prior randomized clinical studies.", "population_specificity": "Elderly Cuban patients (aged \u226560 years) with high vascular risk, including those with hypercholesterolemia, hypertension, and diabetes mellitus.", "effective_dosage": "5, 10, or 20 mg/day, prescribed based on individual atherosclerotic risk.", "study_duration": "Varied; 96.3% treated for 6 months, 82.6% for 12 months, 49.6% for 24 months, and 18.3% for 36 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:37.378280+00:00"}
{"study_id": 32629, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 10, "quality_score": 85, "study_goal": "The researchers aimed to determine whether wheat germ policosanol (WGP) could improve plasma lipid profiles in adults with normal to mildly elevated cholesterol levels.", "results_summary": "The study found that WGP at 20 mg/d had no significant effect on plasma total cholesterol, LDL-cholesterol, HDL-cholesterol, or triacylglycerol concentrations compared to placebo. No adverse effects were observed based on blood chemistry and hematology profiles.", "population_specificity": "58 adults (30 men and 28 women, aged 49 \u00b1 11 years) with normal to mildly elevated plasma cholesterol concentrations.", "effective_dosage": "20 mg/d", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:38.071304+00:00"}
{"study_id": 32630, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether policosanol could prevent bone loss in ovariectomized rats, comparing its effects to estradiol.", "results_summary": "Policosanol prevented bone loss and decreased bone resorption in ovariectomized rats, similar to estradiol, though it did not prevent an increase in osteoblast surface area as estradiol did.", "population_specificity": "Ovariectomized Sprague Dawley female rats (a model for postmenopausal osteoporosis).", "effective_dosage": "50 and 200 mg/kg/day", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:38.443272+00:00"}
{"study_id": 32632, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the efficacy and tolerability of policosanol 5 mg/d in patients with borderline to mildly elevated serum total cholesterol levels.", "results_summary": "Policosanol significantly reduced LDL-C, TC, and TG levels while increasing HDL-C levels, with 84% of treated patients achieving a \u226515% decrease in LDL-C. The treatment was well tolerated, with minimal adverse events.", "population_specificity": "Men and women aged 25-75 with serum TC levels \u22654.8 to <6.0 mmol/L.", "effective_dosage": "5 mg once daily with the evening meal.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:39.364416+00:00"}
{"study_id": 32631, "supplement_id": 1458, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of policosanol and ticlopidine on walking distances and lipid profiles in patients with moderately severe intermittent claudication.", "results_summary": "Policosanol significantly improved walking distances and lipid profiles (lowering LDL-C and TC, raising HDL-C) without significant adverse effects, performing similarly to ticlopidine but with additional cholesterol-lowering benefits.", "population_specificity": "Patients with moderately severe intermittent claudication.", "effective_dosage": "10 mg twice daily (bid).", "study_duration": "20 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:39.765951+00:00"}
{"study_id": 32633, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of policosanol and lovastatin on patients with moderately severe intermittent claudication, focusing on walking distances, cholesterol levels, and quality of life.", "results_summary": "Policosanol significantly improved walking distances (initial and absolute claudication distances), increased HDL-C, reduced LDL-C and fibrinogen levels, and enhanced quality of life compared to lovastatin, which showed no significant improvements in these areas.", "population_specificity": "Patients with moderately severe intermittent claudication.", "effective_dosage": "10 mg once daily.", "study_duration": "20 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:43.704047+00:00"}
{"study_id": 32634, "supplement_id": 1458, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and tolerability of policosanol with atorvastatin in older patients with type II hypercholesterolaemia.", "results_summary": "Policosanol significantly reduced LDL-C, TC, atherogenic ratios, and triglycerides, though less effectively than atorvastatin, but increased HDL-C levels. It was better tolerated with fewer adverse events compared to atorvastatin.", "population_specificity": "Older patients (60-80 years) with type II hypercholesterolaemia.", "effective_dosage": "10 mg/day taken once daily with the evening meal.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:43.822720+00:00"}
{"study_id": 32636, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of 20 mg/day and 40 mg/day policosanol on platelet aggregation in healthy volunteers and type II hypercholesterolaemic patients.", "results_summary": "Policosanol at both 20 mg/day and 40 mg/day moderately reduced platelet aggregation induced by arachidonic acid, collagen, and ADP, with no significant difference between the two doses. It also significantly lowered LDL-cholesterol and total cholesterol while increasing HDL-cholesterol, but triglyceride reductions were not significant compared to placebo.", "population_specificity": "Healthy volunteers and type II hypercholesterolaemic patients.", "effective_dosage": "20 mg/day and 40 mg/day, administered once daily.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:47.049528+00:00"}
{"study_id": 32635, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine whether policosanol could provide health benefits comparable to statins, particularly in cholesterol reduction and isoprenylation inhibition, while being safer and more affordable.", "results_summary": "Policosanol demonstrated cholesterol-lowering effects similar to statins and showed potential to inhibit isoprenylation reactions, leading to benefits like reduced ischemic stroke risk and improved cardiovascular health, without significant toxicity. However, it was less potent than statins in down-regulating HMG-CoA reductase.", "population_specificity": "Patients with significant symptomatic coronary disease (mentioned in the context of Esselstyn's study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:47.317525+00:00"}
{"study_id": 32639, "supplement_id": 1458, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the cholesterol-lowering effects, safety, and mechanism of action of Policosanol compared to statins.", "results_summary": "Policosanol at doses of 10-20 mg/day significantly lowered total and LDL cholesterol while raising HDL cholesterol, with no effect on triglycerides. It was well-tolerated and safe over >3 years of use, with potential benefits on smooth muscle cell proliferation and platelet aggregation.", "population_specificity": "Patients with type II hypercholesterolemia, healthy volunteers, and animal models.", "effective_dosage": "10-20 mg per day", "study_duration": ">3 years in some studies", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:48.060526+00:00"}
{"study_id": 32637, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Policosanol on serum lipid profiles and cardiovascular risk factors in various populations.", "results_summary": "Policosanol improved lipid profiles (reducing TC and LDL, increasing HDL) and decreased cardiovascular risk factors (LDL oxidation, platelet aggregation, etc.). It performed comparably or better than several statins with fewer side effects and showed no toxicity in high-dose animal studies.", "population_specificity": "Healthy volunteers, patients with type II hypercholesterolemia, type 2 diabetics with hypercholesterolemia, postmenopausal women with hypercholesterolemia, and patients with combined hypercholesterolemia and abnormal liver function tests (all Cuban subjects).", "effective_dosage": "5-20 mg daily", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:48.090202+00:00"}
{"study_id": 32638, "supplement_id": 1458, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to investigate the long-term effects of policosanol on lipid profiles and safety in older patients with hypertension and type II hypercholesterolaemia without a history of coronary or cerebrovascular disease.", "results_summary": "Policosanol significantly reduced LDL-C, total cholesterol, triglycerides, and improved HDL-C levels while also lowering systolic blood pressure. It demonstrated fewer serious adverse events and better tolerability compared to placebo.", "population_specificity": "Older male and female patients with hypertension and type II hypercholesterolaemia, no history of coronary or cerebrovascular disease.", "effective_dosage": "5 mg/day initially, increased to 10 mg/day if total cholesterol remained >6.1 mmol/L after 6 months.", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:49.302365+00:00"}
{"study_id": 32640, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the cholesterol-lowering efficacy and tolerability of policosanol at 20 mg/day versus 40 mg/day in patients with type II hypercholesterolemia.", "results_summary": "Policosanol at both 20 mg/day and 40 mg/day significantly lowered LDL-cholesterol, total cholesterol, and triglycerides while increasing HDL-cholesterol, with no significant differences between the two doses. The tolerability profile was excellent, with no unexpected adverse effects.", "population_specificity": "Patients with type II hypercholesterolemia and dyslipidemia associated with noninsulin dependent diabetes mellitus.", "effective_dosage": "20 mg/day and 40 mg/day", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:49.716852+00:00"}
{"study_id": 32641, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether policosanol affects cholesterol biosynthesis by modulating HMG-CoA reductase activity.", "results_summary": "Policosanol reduced cholesterol biosynthesis in a dose-dependent manner when cells were exposed to lipid-depleted medium, suggesting an effect on HMG-CoA reductase. However, direct enzyme inhibition was not observed, indicating a possible modulatory effect on reductase synthesis or degradation.", "population_specificity": "Vero fibroblasts (in vitro study)", "effective_dosage": "0.5-50 \u00b5g/mL", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:51.165985+00:00"}
{"study_id": 32642, "supplement_id": 1458, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to investigate the long-term effects of policosanol on patients with moderately severe intermittent claudication, focusing on walking distances and symptom improvement.", "results_summary": "Policosanol significantly increased initial and absolute claudication distances compared to placebo, with sustained improvements over 2 years. It also improved the ankle/arm pressure index and reduced lower limb symptoms, with fewer serious adverse events than placebo.", "population_specificity": "Patients with moderately severe intermittent claudication.", "effective_dosage": "10 mg twice daily.", "study_duration": "2 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:52.448417+00:00"}
{"study_id": 32643, "supplement_id": 1458, "safety_score": "95", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effect of policosanol on LDL-C susceptibility to in vitro lipid peroxidation in healthy human volunteers.", "results_summary": "Policosanol significantly and dose-dependently increased the lag phase of conjugated diene generation, decreased the rate of conjugated diene generation, and inhibited macrophage-mediated oxidation. It also lowered total cholesterol and LDL-C while increasing HDL-C, with no reported adverse effects.", "population_specificity": "69 healthy human volunteers", "effective_dosage": "5 mg/day and 10 mg/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:55.684158+00:00"}
{"study_id": 32646, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of isopolicosanol and octacosanol on reaction time and related brain activity in healthy students.", "results_summary": "After treatment, groups receiving isopolicosanol and octacosanol showed reduced reaction times, with isopolicosanol also exhibiting increased CNV amplitudes and shorter P3 latencies in the simple reaction time test. No significant changes were observed in the placebo group.", "population_specificity": "Thirty sedentary healthy students", "effective_dosage": "3.6 mg per day", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:56.491744+00:00"}
{"study_id": 32645, "supplement_id": 1458, "safety_score": "95", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy, safety, and tolerability of policosanol in lowering cholesterol levels in postmenopausal women with type II hypercholesterolemia.", "results_summary": "Policosanol significantly reduced LDL-C and total cholesterol levels while increasing HDL-C, with greater effects at higher doses. It was well tolerated, with no drug-related adverse events and fewer serious adverse events compared to placebo.", "population_specificity": "Postmenopausal women with type II hypercholesterolemia.", "effective_dosage": "5 mg/day for 12 weeks, then 10 mg/day for another 12 weeks.", "study_duration": "24 weeks (12 weeks per dosage phase).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:57.439783+00:00"}
{"study_id": 32647, "supplement_id": 1458, "safety_score": "95", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and tolerability of policosanol versus acipimox in patients with type II hypercholesterolemia.", "results_summary": "Policosanol significantly reduced total cholesterol (15.8%), LDL-cholesterol (21%), and improved cholesterol ratios more effectively than acipimox, with no reported adverse effects. Acipimox showed milder cholesterol reductions and caused adverse effects in some patients.", "population_specificity": "Patients with type II hypercholesterolemia.", "effective_dosage": "10 mg/day of policosanol.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:57.478249+00:00"}
{"study_id": 32648, "supplement_id": 1458, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the cholesterol-lowering efficacy of policosanol with HMG CoA inhibitors (lovastatin and simvastatin) in patients with elevated LDL cholesterol.", "results_summary": "Policosanol reduced LDL cholesterol by 24%, outperforming lovastatin (22%) and simvastatin (15%). HDL cholesterol significantly increased in the policosanol group, with no adverse hepatic effects and only mild, unspecific side effects reported.", "population_specificity": "Patients with LDL cholesterol over 160 mg/dl after 6 weeks of diet.", "effective_dosage": "10 mg/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:58.438337+00:00"}
{"study_id": 32650, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of policosanol on platelet aggregation in type II hypercholesterolemic patients.", "results_summary": "Policosanol significantly reduced platelet aggregation induced by arachidonic acid and collagen, and inhibited aggregation at the lowest dose of ADP (0.5 uM). No adverse events were reported, and only one placebo patient discontinued due to arthralgia.", "population_specificity": "Type II hypercholesterolemic patients with total cholesterol > 5.0 mmol/L despite dietary therapy.", "effective_dosage": "10 mg/day", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:00.715947+00:00"}
{"study_id": 32649, "supplement_id": 1458, "safety_score": "95", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy, safety, and tolerability of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors.", "results_summary": "Policosanol significantly reduced LDL cholesterol (18.2% at 5 mg, 25.6% at 10 mg) and total cholesterol (13.0% at 5 mg, 17.4% at 10 mg), while increasing HDL cholesterol (15.5% at 5 mg, 28.4% at 10 mg). It was safe and well-tolerated, with no serious adverse events reported in the policosanol group compared to placebo.", "population_specificity": "Patients with type II hypercholesterolemia and additional coronary risk factors.", "effective_dosage": "5 mg once daily for 12 weeks, then 10 mg once daily for the next 12 weeks.", "study_duration": "24 weeks (12 weeks per dosage phase).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:02.341115+00:00"}
{"study_id": 32651, "supplement_id": 1458, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and tolerability of policosanol in improving walking distances and reducing symptoms in patients with intermittent claudication.", "results_summary": "Policosanol significantly increased initial and absolute claudication distances compared to placebo, with fewer adverse events and better tolerability. The policosanol group showed a lower incidence of adverse events and no serious vascular events, unlike the placebo group.", "population_specificity": "Patients with intermittent claudication (n=62, randomized 31 per group).", "effective_dosage": "10 mg twice daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:04.138086+00:00"}
{"study_id": 32652, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of long-term policosanol therapy on clinical evolution and exercise-ECG responses in coronary heart disease patients with myocardial ischemia.", "results_summary": "Policosanol improved functional capacity, reduced angina and cardiac events, and enhanced aerobic performance, with greater benefits when combined with aspirin. Lipid levels also improved.", "population_specificity": "45 coronary heart disease patients with myocardial ischemia.", "effective_dosage": "5 mg twice daily (with or without 125 mg aspirin).", "study_duration": "20 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:04.502961+00:00"}
{"study_id": 32654, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of policosanol on platelet aggregation and thromboxane B2 and prostacyclin production in healthy volunteers.", "results_summary": "Policosanol significantly reduced arachidonic acid and collagen-induced platelet aggregation and inhibited thromboxane generation induced by collagen, but did not affect prostacyclin production.", "population_specificity": "Healthy volunteers", "effective_dosage": "10 mg/day", "study_duration": "15 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:04.614542+00:00"}
{"study_id": 32653, "supplement_id": 1458, "safety_score": "80", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of policosanol, both alone and in combination with warfarin, on bleeding time and venous thrombosis in rats.", "results_summary": "Policosanol did not prolong bleeding time, while warfarin alone and the combination with policosanol did. Policosanol and warfarin monotherapies significantly reduced thrombus weight, but the combination showed no additional benefits.", "population_specificity": "Rats (experimental models)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Warfarin (moderate prolongation of bleeding time when combined, but no enhancement beyond warfarin alone)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:06.581879+00:00"}
{"study_id": 32644, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy and tolerability of policosanol (10 mg/day) versus lovastatin (20 mg/day) in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.", "results_summary": "Policosanol significantly lowered LDL-cholesterol (20.4%), total cholesterol (14.2%), and the LDL/HDL ratio (23.7%), while also increasing HDL-cholesterol (7.5%). It demonstrated better safety and tolerability than lovastatin, with fewer adverse reactions.", "population_specificity": "Patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.", "effective_dosage": "10 mg/day", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:07.130350+00:00"}
{"study_id": 32655, "supplement_id": 1458, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to compare the effects of policosanol, aspirin, and their combination on platelet aggregation in healthy volunteers.", "results_summary": "Policosanol significantly reduced platelet aggregation induced by ADP, epinephrine, and collagen, with efficacy comparable to aspirin. Combination therapy showed the highest reductions in platelet aggregation, particularly for collagen and epinephrine, without significant changes in coagulation time.", "population_specificity": "43 healthy volunteers", "effective_dosage": "20 mg day-1", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:07.278890+00:00"}
{"study_id": 32656, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether policosanol could reduce plasma LDL-cholesterol levels in rabbits with casein-induced hypercholesterolemia by inhibiting hepatic cholesterol biosynthesis and enhancing LDL catabolism.", "results_summary": "Policosanol significantly reduced plasma total cholesterol and LDL-cholesterol levels, inhibited hepatic cholesterol biosynthesis, and enhanced LDL clearance via increased receptor-mediated uptake by the liver.", "population_specificity": "Rabbits fed a wheat starch-casein diet to induce hypercholesterolemia.", "effective_dosage": "50 mg/kg administered orally once daily.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:08.348968+00:00"}
{"study_id": 32658, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether policosanol inhibits hepatic cholesterol biosynthesis in rats and its potential mechanism of action.", "results_summary": "Policosanol reduced hepatic cholesterol biosynthesis by approximately 20% in rats, as measured by 3H-water incorporation, but did not directly inhibit HMG-CoA reductase activity.", "population_specificity": "Rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:10.953422+00:00"}
{"study_id": 32659, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if orally administered policosanol protects against lipofundin-induced atherosclerotic lesions in rats.", "results_summary": "Policosanol significantly reduced atherosclerotic lesions in treated rats, demonstrating a protective effect against lipofundin-induced aortic lesions. The effect was observed across multiple dosages.", "population_specificity": "Male Wistar rats", "effective_dosage": "0.5, 2.5, 5, and 25 mg kg-1, once daily", "study_duration": "8 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:11.992990+00:00"}
{"study_id": 32657, "supplement_id": 1458, "safety_score": "90", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether policosanol administration over three successive generations of rats affected fertility, reproductive performance, or development.", "results_summary": "The study found no treatment-related adverse effects on fertility, reproductive performance, or development in rats administered policosanol at doses up to 500 mg/kg bw/day. No clinical signs or differences in survival, body weight, or reflexes were observed across generations.", "population_specificity": "Sprague-Dawley rats of both sexes across three generations (F0, F1b, F2b, and F3b offspring).", "effective_dosage": "0, 5, 50, and 500 mg/kg bw/day by gavage.", "study_duration": "Administered throughout three successive generations (specific duration not detailed).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:12.134571+00:00"}
{"study_id": 32661, "supplement_id": 1458, "safety_score": "95", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy, safety, and tolerability of policosanol (5 mg twice daily) in treating type II hyperlipoproteinaemia over a two-year period.", "results_summary": "Policosanol significantly reduced LDL-C (25%) and total cholesterol (18%), raised HDL-C (up to +21%), and maintained these effects over two years with no significant adverse effects compared to placebo.", "population_specificity": "69 patients with type II hyperlipoproteinaemia (both sexes) whose cholesterol was not sufficiently controlled by diet.", "effective_dosage": "5 mg twice daily", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:15.336740+00:00"}
{"study_id": 32662, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to investigate the oral toxicity of policosanol in beagle dogs over 52 weeks and assess its cholesterol-lowering effects.", "results_summary": "Policosanol was well tolerated with no toxic symptoms observed, reduced total cholesterol by approximately 20% without losing effectiveness over time, and did not significantly alter triglycerides or HDL-C. No blood biochemistry or histopathological disturbances were noted.", "population_specificity": "Beagle dogs (12 males and 12 females)", "effective_dosage": "30 mg/kg/day and 180 mg/kg/day, administered daily by gavage", "study_duration": "52 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:15.339059+00:00"}
{"study_id": 32664, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the mechanisms by which policosanol influences cholesterol synthesis and LDL processing in human lung fibroblasts.", "results_summary": "Policosanol inhibited cholesterol synthesis at early steps in the pathway and significantly enhanced LDL binding, internalization, and degradation, even at doses where cholesterol synthesis was not strongly inhibited. The study suggests both sterol-dependent and independent mechanisms may contribute to increased LDL-receptor activity.", "population_specificity": "Human lung fibroblasts (in vitro study)", "effective_dosage": "Dose-dependent (specific amounts not stated)", "study_duration": "48-hour incubation prior to experiment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:16.825997+00:00"}
{"study_id": 32663, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the long-term cholesterol-lowering effects and potential toxicity of policosanol in monkeys.", "results_summary": "Policosanol significantly reduced serum total cholesterol and LDL cholesterol, with effects persisting throughout the 54-week study. No drug-related toxicity was detected, and treated animals showed reduced aortic atherosclerotic lesions compared to controls.", "population_specificity": "Adult male Macaca arctoides monkeys", "effective_dosage": "0.25, 2.5, and 25 mg/kg (oral administration)", "study_duration": "54 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:18.534576+00:00"}
{"study_id": 32665, "supplement_id": 1458, "safety_score": "90", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the oral toxicity and safety profile of policosanol in rats over a 12-month period.", "results_summary": "The study found no treatment-related toxicity in rats, with no significant differences in body weight, food consumption, clinical observations, blood biochemistry, hematology, organ weight ratios, or histopathological findings between control and treated groups. The results suggest a wide safety margin for policosanol with chronic administration.", "population_specificity": "Sprague Dawley rats (20/sex/group)", "effective_dosage": "0.5 to 500 mg/kg daily", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:19.843300+00:00"}
{"study_id": 194708, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of policosanol supplementation on blood glucose levels through a meta-analysis of existing trials.", "results_summary": "Policosanol supplementation significantly reduced blood glucose levels, particularly in individuals under 50 years old and at a dosage of 10 mg/day. The effect was more pronounced in interventions lasting less than 24 weeks, with no evidence of a non-linear dose-response relationship.", "population_specificity": "2680 participants across 25 trials, with subgroup analysis focusing on individuals below 50 years of age.", "effective_dosage": "10 mg/day (most effective dosage noted).", "study_duration": "Varied, with significant effects observed in periods less than 24 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:21.119974+00:00"}
{"study_id": 194709, "supplement_id": 1458, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to systematically review randomized control trials (RCTs) evaluating the efficacy of policosanol supplementation for lowering high blood pressure.", "results_summary": "Policosanol significantly reduced both systolic (SBP) and diastolic (DBP) blood pressure, with pooled effect sizes showing clinically meaningful decreases (SBP: -3.423 mmHg; DBP: -1.468 mmHg). However, significant heterogeneity among studies suggests variability in results.", "population_specificity": "Not specified (general population inferred).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:22.937495+00:00"}
{"study_id": 32660, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "To determine if policosanol could reduce elevated cholesterol and LDL levels in NIDDM patients with hypercholesterolemia.", "results_summary": "Policosanol significantly reduced total cholesterol by 17.5% and LDL cholesterol by 21.8%, raised HDL cholesterol by 11.3%, and decreased triglycerides by 6.6% (nonsignificant). No adverse effects were attributed to policosanol, and glycemic control remained unaffected.", "population_specificity": "29 patients with NIDDM and hypercholesterolemia.", "effective_dosage": "5 mg twice daily (10 mg/day).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:24.032024+00:00"}
{"study_id": 32467, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether \u03b3-PGA from a novel Bacillus subtilis strain could strengthen the skin barrier and improve moisture retention.", "results_summary": "\u03b3-PGA increased mRNA expression of skin barrier markers and hyaluronic acid synthesis in keratinocytes and elevated key protein expression in a reconstructed skin model, suggesting improved skin barrier function and hydration.", "population_specificity": "In vitro keratinocytes and a reconstructed skin model.", "effective_dosage": "1% \u03b3-PGA (topical application in the skin model; dose-dependent effects in keratinocytes).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:25.093338+00:00"}
{"study_id": 194710, "supplement_id": 1458, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "To determine the effect of policosanol (as part of a dietary supplement) at twice the recommended dose versus the usual dose or placebo on blood lipid profiles and safety biomarkers in hypercholesterolemic subjects.", "results_summary": "Both doses significantly reduced LDL-C compared to placebo, with no additional benefit from the higher dose. No adverse effects on muscle, liver, or renal function were observed, and mitochondrial function in rat muscle fibers was unaffected.", "population_specificity": "45 healthy subjects with untreated hypercholesterolemia (15 per group).", "effective_dosage": "3 tablets (usual dose) and 6 tablets (twice the recommended dose) daily.", "study_duration": "4 weeks of supplementation followed by 4 weeks of withdrawal.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:25.199915+00:00"}
{"study_id": 32466, "supplement_id": 1459, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Poly-\u03b3-Glutamic Acid (\u03b3-PGA) could alleviate slow transit constipation (STC) in mice by improving intestinal function, reducing inflammation, and modulating gut microbiota.", "results_summary": "\u03b3-PGA significantly increased defecation frequency and fecal water content, repaired intestinal damage, reduced inflammatory markers, improved tight junction proteins, and positively altered gut microbiota composition. The high-dose group (10 g/kg/d) outperformed lower doses and the positive control (PEG).", "population_specificity": "Loperamide-induced STC in mice.", "effective_dosage": "Low-, medium-, and high-dose groups (specific amounts not detailed except for high-dose: 10 g/kg/d).", "study_duration": "One week.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:26.178414+00:00"}
{"study_id": 32469, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of Poly-\u03b3-Glutamic Acid (\u03b3-PGA) biopreparation on ameliorating coastal saline soil by analyzing soil properties and plant growth.", "results_summary": "The study found that \u03b3-PGA significantly improved saline soil conditions, reducing soil evaporation and salt content while increasing plant growth, soil nutrient content, and microbial populations. The PGAB treatment showed the most pronounced effects, with statistically significant improvements across multiple metrics.", "population_specificity": "Coastal saline soil and associated plant growth.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:26.784136+00:00"}
{"study_id": 32470, "supplement_id": 1459, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to develop an injectable hydrogel using Poly-\u03b3-Glutamic Acid (\u03b3-PGA) as a barrier and drug carrier to prevent and treat postoperative abdominal adhesions while improving the bioavailability of meloxicam.", "results_summary": "The study found that the \u03b3-PGA-based hydrogel exhibited good biosafety, biodegradability, and controlled release of meloxicam, effectively inhibiting inflammatory responses and balancing the fibrinolytic system in injured tissues. The hydrogel also demonstrated tunable mechanical properties, high antioxidant capacity, and biocompatibility.", "population_specificity": "In vivo models (specific species not mentioned in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:28.896023+00:00"}
{"study_id": 32471, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effects of Poly-\u03b3-Glutamic Acid (\u03b3-PGA) on soil characteristics, microbial community, and metabolic function under short-term drought conditions.", "results_summary": "\u03b3-PGA improved soil mechanical composition, infiltration capacity, and organic matter content under drought. It also enhanced soil microbiota structure and influenced metabolic pathways, particularly amino acid and vitamin metabolism.", "population_specificity": "Soil and maize under drought conditions.", "effective_dosage": "Not specified", "study_duration": "Short-term drought conditions (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:29.378346+00:00"}
{"study_id": 32473, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether \u03b3-PGA could enhance the environmental stress resistance, functional properties, and anti-flocculation effects of shellac-curcumin nanoparticles (S-Cur-NPs).", "results_summary": "\u03b3-PGA improved the encapsulation efficiency, loading capacity, and stability of S-Cur-NPs, reducing flocculation during heating, storage, and digestion. It also enhanced antibacterial and antioxidant properties while enabling targeted intestinal release.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:32.449787+00:00"}
{"study_id": 32472, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of Poly-\u03b3-Glutamic Acid (PGA) hydrogels as adsorbents for removing heavy metal ions (Cu2+, Cr6+, Zn2+) from wastewater.", "results_summary": "The PGA hydrogels demonstrated good adsorption capacity for heavy metal ions, particularly Cu2+, through electrostatic and coordination interactions. The hydrogels were recyclable and maintained high adsorption capability after five cycles, indicating potential for wastewater treatment.", "population_specificity": "Not applicable (in vitro study on wastewater treatment).", "effective_dosage": "Not specified (study focused on hydrogel preparation and adsorption parameters).", "study_duration": "Not specified (study evaluated adsorption parameters like contact time but did not specify a fixed intervention duration).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:32.605660+00:00"}
{"study_id": 32474, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to understand how Poly-\u03b3-Glutamic Acid (\u03b3-PGA) improves soil structure, soybean productivity, and water-use efficiency in arid regions.", "results_summary": "\u03b3-PGA significantly improved soybean yield, photosynthesis, chlorophyll content, and water-use efficiency while enhancing soil aggregate stability and water content, with the most pronounced effects at 40 kg ha\u207b\u00b9 (P3).", "population_specificity": "Soybean crops in the arid region of northwest China.", "effective_dosage": "0 (CK), 10 (P1), 20 (P2), 40 (P3), and 80 kg ha\u207b\u00b9 (P4).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:34.087672+00:00"}
{"study_id": 32476, "supplement_id": 1459, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to explore the properties and applications of Poly-\u03b3-Glutamic Acid (\u03b3-PGA) across various industries, including healthcare, food, agriculture, and cosmetics.", "results_summary": "The study found that \u03b3-PGA is biodegradable, safe for humans, and has versatile applications such as a thickener, drug carrier, moisturizer, and environmental stabilizer. Its unique properties enable effective use in multiple domains without reported adverse effects.", "population_specificity": "Not specified (broad applications across industries)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:34.116815+00:00"}
{"study_id": 32475, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the adsorption capacities of different \u03b3-PGA variants for heavy metals (Cu, Pb, Cd) in aqueous environments and assess their potential as biosorbents for wastewater treatment.", "results_summary": "Na-bonded \u03b3-PGA with high molecular weight showed the highest heavy metal adsorption (92.2-98.3%), particularly at 0.5% concentration, with superior selectivity for Pb ions (85.4%) in mixed heavy metal environments. The study highlights \u03b3-PGA's potential as a biodegradable and non-toxic biosorbent for environmental cleanup.", "population_specificity": "Not specified (in vitro study on heavy metal adsorption in aqueous environments)", "effective_dosage": "0.5% concentration", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:34.471545+00:00"}
{"study_id": 32478, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether incorporating Poly-\u03b3-Glutamic Acid (PGA) into LNP/mRNA complexes could enhance mRNA intracellular release and transfection efficacy in vitro and in vivo.", "results_summary": "The optimized LNP/mRNA/PGA formulation increased mRNA expression by 3-fold in HeLa cells and up to 5-fold in mice, attributed to improved intracellular mRNA release. PGA incorporation did not significantly alter biodistribution or biosafety profiles.", "population_specificity": "HeLa cells (in vitro) and mice (in vivo).", "effective_dosage": "PGA with molecular weights of 80 kDa or 200 kDa at a charge ratio (N/P/C) of 25/1/1.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:37.768443+00:00"}
{"study_id": 32479, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a multifunctional PGA hydrogel containing H2S donor, ciprofloxacin, and anthocyanins could accelerate diabetic wound healing by reducing inflammation, promoting angiogenesis, and enhancing antibacterial activity.", "results_summary": "The PGA hydrogel demonstrated effective H2S release, promoting cell proliferation, anti-inflammatory and antioxidant activity, and accelerated antibiotic release under diabetic wound conditions. In vivo results showed reduced inflammation, enhanced angiogenesis, and faster wound healing.", "population_specificity": "Diabetic wound models (in vivo study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:38.281316+00:00"}
{"study_id": 32477, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to investigate the antibacterial and biofilm-inhibitory effects of Poly-\u03b3-Glutamic Acid nanoparticles (\u0194-PGA NP) against clinical and reference strains of Gram-positive and Gram-negative bacteria, as well as its potential in wound healing.", "results_summary": "\u0194-PGA NP demonstrated strong inhibitory effects against bacterial biofilms, with varying MIC, MBEC, and MBIC values across strains. In vivo experiments showed accelerated wound healing in treated mice compared to untreated controls, with significant bacterial eradication.", "population_specificity": "Clinical and reference bacterial strains (Staphylococcus aureus, Streptococcus pyogenes, Escherichia coli, Klebsiella pneumoniae) and mice with induced wounds.", "effective_dosage": "MIC values ranged from 0.2\u20133.2 \u03bcg/mL; MBEC and MBIC values varied by strain and exposure time (e.g., 0.1\u20131.6 \u03bcg/mL).", "study_duration": "In vitro exposure times ranged from 12\u201348 hours; in vivo wound healing was monitored up to 72 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:38.914112+00:00"}
{"study_id": 32481, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of \u03b3-PGA NPs as antigen carriers and adjuvants for anti-cancer vaccination by assessing their ability to modulate the tumor microenvironment and stimulate systemic anti-tumor immunity.", "results_summary": "The study found that \u03b3-PGA NPs are readily taken up by dendritic cells, leading to cytokine secretion and enhanced T-cell stimulation, which contributes to systemic anti-tumor immunity and tumor growth inhibition. The NPs demonstrated intrinsic adjuvant and antigen carrier properties, making them promising for cancer vaccination strategies.", "population_specificity": "Not specified (review of existing research, not a clinical study).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:41.404456+00:00"}
{"study_id": 32482, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of poly-\u03b3-glutamic acid (\u03b3-PGA) on postharvest physiology and quality of strawberries during cold storage.", "results_summary": "\u03b3-PGA, particularly at 100 mg\u00b7L-1, significantly improved decay control, antioxidant capacity, firmness, color, and nutritional quality of strawberries, while also enhancing sensory attributes like sugar-acid ratio.", "population_specificity": "Strawberry cv. Hongyan", "effective_dosage": "100 mg\u00b7L-1", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:41.761389+00:00"}
{"study_id": 32480, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to optimize the production of \u03b3-PGA using Bacillus sp. YJY-8 and evaluate its effects on tomato plant growth and yield.", "results_summary": "The study achieved high \u03b3-PGA production levels (65.2 g/L in flasks, 88.42 g/L in fermenters) and demonstrated that \u03b3-PGA treatment improved tomato plant growth metrics (height, stem diameter) and yield (increased by 5.83-14.27%).", "population_specificity": "Tomato plants (seedling, flowering/fruiting, and maturation stages).", "effective_dosage": "Not specified for plant treatment (only production levels provided).", "study_duration": "19 days for seedling stage; full growth cycle for yield assessment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:43.159436+00:00"}
{"study_id": 32484, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether poly-\u03b3-glutamic acid-modified cationic liposomes (\u03b3-PGA-CL) could effectively co-deliver pemetrexed disodium (PMX) and siRNA to treat non-small cell lung cancer (NSCLC).", "results_summary": "The study found that \u03b3-PGA-CL enhanced cellular uptake, protected siRNA from degradation, and significantly inhibited tumor growth in both in vitro and in vivo models. It also promoted apoptosis by suppressing Bcl-2 mRNA and protein expression.", "population_specificity": "A549 cells (in vitro) and LLC-bearing BABL/c mice (in vivo).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:43.973144+00:00"}
{"study_id": 32483, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the optimal application rate of Poly-\u03b3-Glutamic Acid (\u03b3-PGA) for improving biological nitrogen fixation, water-N productivity, and nitrate distribution in a cotton/soybean intercropping system.", "results_summary": "The study found that \u03b3-PGA enhanced growth indicators, biological nitrogen fixation, and water-N productivity in cotton and soybean, with peak effects observed at 0.2% (P2) and 0.3% (P3) application rates. The optimal \u03b3-PGA rate for maximizing yield and efficiency was determined to be 0.22%.", "population_specificity": "Cotton/soybean intercropping system (potted experiment)", "effective_dosage": "0%, 0.1%, 0.2%, 0.3%, and 0.4% (represented by CK, P1, P2, P3, and P4, respectively)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:44.312698+00:00"}
{"study_id": 32486, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how poly-\u03b3-glutamic acid (\u03b3-PGA) affects maize root development and its potential mechanisms, including gene expression and microbial interactions.", "results_summary": "\u03b3-PGA significantly improved maize root growth by increasing lateral root number (71.87% higher than control) and length, upregulating auxin-related genes, and promoting growth-promoting bacteria in rhizosphere soil.", "population_specificity": "Maize plants", "effective_dosage": "Not specified", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:45.882498+00:00"}
{"study_id": 32485, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Poly-\u03b3-Glutamic Acid (PGA) could effectively remove humic acid (HA) interference in soil enzymatic analysis using a coagulation-flocculation process.", "results_summary": "PGA, combined with aluminum trivalent, achieved >92% HA removal efficiency in neutral pH conditions. While fluorescent intensity of the enzyme product decreased by 50%, detection of TMB remained unaffected, suggesting the method is suitable for reducing HA interference without compromising target analyte detection.", "population_specificity": "Soil samples (not human or animal subjects).", "effective_dosage": "100 mg L-1 PGA.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:47.491822+00:00"}
{"study_id": 32487, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether poly-\u03b3-glutamic acid (\u03b3-PGA) could improve the thermotolerance of Chinese cabbage seedlings under heat stress.", "results_summary": "\u03b3-PGA priming enhanced thermotolerance in Chinese cabbage by improving vegetative growth, gas exchange, chlorophyll fluorescence, and antioxidant activity while reducing oxidative stress markers. It also upregulated genes related to stress response and metabolic pathways.", "population_specificity": "Cool-season Chinese cabbage (Brassica rapa L. ssp. pekinensis) seedlings.", "effective_dosage": "20 mg\u00b7L\u207b\u00b9, applied as daily foliar sprays for 5 days.", "study_duration": "5 days of priming followed by 5 days of heat stress.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:47.762637+00:00"}
{"study_id": 32489, "supplement_id": 1459, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Poly-\u03b3-Glutamic Acid (PGA) coating on nanoparticles could enhance renal drug distribution and cellular uptake in diabetic nephropathy mice.", "results_summary": "PGA-coated nanoparticles improved renal drug distribution and cellular uptake via GGT binding, prolonged blood circulation, and significantly restored renal function in diabetic nephropathy mice.", "population_specificity": "Streptozotocin-induced diabetic nephropathy mice.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:49.104309+00:00"}
{"study_id": 32488, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to characterize the structural features of poly-\u03b3-glutamic acid (\u03b3-PGA) complexed with heavy metal ions (Pb2+ and Cu2+) and understand their role in the flocculation process and mechanism.", "results_summary": "The study found that \u03b3-PGA-Pb complexes underwent significant structural changes, promoting flocculation, while \u03b3-PGA-Cu complexes showed minimal structural alteration, hindering flocculation. The structural evolution of \u03b3-PGA-Pb was key to its effectiveness in heavy metal removal, particularly in specific pH ranges.", "population_specificity": "Not applicable (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:50.240894+00:00"}
{"study_id": 32491, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to prepare and evaluate films made of Poly-\u03b3-Glutamic Acid (PGA) or a combination of PGA and Poly-\u03b5-Lysine (PL) for potential use as wound dressings, assessing their organoleptic, physicochemical, and mechanical properties.", "results_summary": "The study successfully produced films with mutual compatibility between PGA and PL, demonstrating satisfactory properties for wound application, including ease of handling, mechanical strength, and physicochemical stability.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:52.048963+00:00"}
{"study_id": 32490, "supplement_id": 1459, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and hemostatic efficacy of composite hemostatic microspheres made from poly(\u03b3-glutamic acid) (\u03b3-PGA) and sodium alginate (SA) in comparison to existing hemostatic agents.", "results_summary": "The SA/\u03b3-PGA microspheres demonstrated good biocompatibility, water absorptivity, and viscosity, with better hemostatic effects in animal models (liver, spleen, and femoral artery bleeding) than a microporous polysaccharide powder compound. Safety tests (hemolysis, pyrogenic, and intradermal irritation) indicated good tolerability in vivo.", "population_specificity": "Animal models (specific species not mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:52.574434+00:00"}
{"study_id": 32493, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to enhance \u03b3-PGA production in Bacillus licheniformis WX-02 by engineering central carbon metabolism to improve yield and reduce production costs.", "results_summary": "Metabolic engineering strategies, including overexpression of pyruvate dehydrogenase and citrate synthase, down-regulation of isocitrate lyase, and deletion of pyruvate formate-lyase, increased \u03b3-PGA yield by up to 69.30%, achieving a titer of 12.02 g/L.", "population_specificity": "Bacillus licheniformis WX-02 (bacterial strain)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:54.598509+00:00"}
{"study_id": 32492, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential of \u03b3-PGA-based electrospun nanofibers, combined with PVA and chlorogenic acid, as a wound dressing for diabetic foot treatment.", "results_summary": "The study found that \u03b3-PGA blended with PVA improved chlorogenic acid release compared to pure PVA nanofibers, with higher \u03b3-PGA concentrations (10%) achieving 66% release within 24 hours. The nanofibers exhibited cross-linking due to hydrogen bonding interactions, enhancing drug delivery efficiency.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "5% and 10% \u03b3-PGA (w/v) blended with 10% PVA", "study_duration": "Not specified (release measured over 24 hours)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:54.743089+00:00"}
{"study_id": 32495, "supplement_id": 1459, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the biosynthetic mechanism, production methods, metabolic engineering strategies, and potential applications of Poly-\u03b3-Glutamic Acid (\u03b3-PGA), as well as challenges in reducing production costs for commercialization.", "results_summary": "The study highlights \u03b3-PGA's biodegradable, non-toxic, and ecofriendly properties, its potential in various industries, and the challenges of high production costs and lower productivity. It also discusses metabolic engineering and recovery processes to address these challenges.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:55.833811+00:00"}
{"study_id": 32497, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop and evaluate a hydrogel composed of Poly-\u03b3-Glutamic Acid (\u03b3-PGA), Chitooligo-saccharide, and Papain for its potential to inhibit hypertrophic scar formation during wound healing.", "results_summary": "The G/C/P hydrogel demonstrated good structural properties, facilitated cell adhesion, inhibited excessive fibroblast proliferation, and effectively reduced collagen deposition and hypertrophic scar formation in a rabbit ear wound model.", "population_specificity": "Rabbit ear skin wound model (animal study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:58.376981+00:00"}
{"study_id": 32494, "supplement_id": 1459, "safety_score": "90", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether supplementation with Poly-\u03b3-Glutamic Acid (\u03b3-PGA) and vitamin B6 (VitB6) improves sleep duration and quality in healthy adults.", "results_summary": "The study found that dual supplementation of \u03b3-PGA and VitB6 significantly improved sleep duration and quality, as measured by the Pittsburgh Sleep Quality Index, compared to placebo. No significant changes were observed with \u03b3-PGA or VitB6 alone, and no side effects were reported.", "population_specificity": "47 healthy adults (25 men and 22 women) without chronic disease.", "effective_dosage": "\u03b3-PGA 600 mg daily, VitB6 100 mg daily.", "study_duration": "1-month intervention periods separated by a 1-month washout.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:00.612471+00:00"}
{"study_id": 32499, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Poly-\u03b3-Glutamic Acid bioproduct (PGAB) could conserve soil nitrogen and improve microbial activity during salt-leaching in saline soils.", "results_summary": "PGAB significantly reduced soil salinity by 39.9%, increased soil total nitrogen, enhanced microbial biomass nitrogen by 119.5%, and improved soil physical properties, including aggregate stability and erosion resistance.", "population_specificity": "Coastal saline soil (0-30 cm depth)", "effective_dosage": "Not specified", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:00.676672+00:00"}
{"study_id": 32501, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the remineralization potential of a \u03b3-PGA/TCP composite in preventing caries compared to other treatments.", "results_summary": "The \u03b3-PGA/TCP composite showed the least lesion depth and mineral loss, the highest hardness, and prominent intra- and inter-tubular precipitates, outperforming other groups. XRD patterns resembled sound dentin, and wettability improved after treatment.", "population_specificity": "Demineralized bovine dentin specimens", "effective_dosage": "Not specified", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:02.250616+00:00"}
{"study_id": 32496, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a bionic extracellular matrix hydrogel using Poly-\u03b3-Glutamic Acid (\u03b3-PGA-SH) and oxidized hyaluronic acid (HA-CHO) to enhance wound healing by mimicking the skin's microenvironment.", "results_summary": "The hydrogels demonstrated adaptability, self-healing capability, viscoelastic properties similar to natural ECM, and free radical scavenging. They significantly improved wound healing in a full-thickness skin defect model compared to commercial dressings by promoting angiogenesis and collagen deposition.", "population_specificity": "Full-thickness skin defect model (in vivo study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:02.251523+00:00"}
{"study_id": 32500, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the mechanism of GGT up-regulation using \u03b3-pGluA-derived nanopolyplexes (PCFN) for enhanced tumor targeting and synergistic therapy.", "results_summary": "The study found that PCFN/MA induced intracellular oxidative stress, which upregulated GGT expression, improving tumor targeting and sensitizing tumors for synergistic therapy. The strategy demonstrated potential for augmenting active targeting by disrupting redox homeostasis.", "population_specificity": "Tumor cells (specific human population not specified).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:02.523661+00:00"}
{"study_id": 32502, "supplement_id": 1459, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the biocompatibility and antimicrobial efficacy of \u03b3-PGA-TMPyP nanofibrous mats for infected wound healing.", "results_summary": "The nanofibrous mats demonstrated potent bactericidal activity under visible light, effectively eradicating broad-spectrum bacteria at low TMPyP doses (0.1 wt%), while showing good biocompatibility with no adverse effects on mammalian cells or RBCs. In vivo tests confirmed reduced inflammation and improved wound healing with negligible local toxicity.", "population_specificity": "Animal models (in vivo) and in vitro cell cultures.", "effective_dosage": "0.1 wt% TMPyP loading dose.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:05.068755+00:00"}
{"study_id": 32503, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of \u03b3-PGA-based nanoparticles in enhancing cancer immunotherapy through combined starving therapy, photodynamic therapy, photothermal therapy, and checkpoint-blockade immunotherapy.", "results_summary": "The \u03b3-PGA@GOx@Mn,Cu-CDs nanoparticles demonstrated prolonged retention in the tumor microenvironment, targeted cancer cells, and exhibited photothermal and photodynamic effects under laser irradiation. The treatment significantly improved tumor hypoxia and enhanced in vivo photodynamic therapy, leading to improved antitumor immune responses and potential metastasis inhibition.", "population_specificity": "Not specified (likely preclinical study involving tumor models).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:07.390192+00:00"}
{"study_id": 32504, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of a thermo-sensitive hydrogel containing Poly-\u03b3-Glutamic Acid (PP) loaded with superoxide dismutase (SOD) in promoting wound healing, particularly in chronic trauma repair.", "results_summary": "The study found that the PP hydrogel exhibited thermo-sensitivity at physiological temperature, high swelling rate, and good water retention, which facilitated wound healing. The SOD-PP hydrogel showed superior wound closure rates in diabetic rats compared to other treatments, with maintained SOD activity in vitro.", "population_specificity": "Diabetic rat model (in vivo)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:09.045931+00:00"}
{"study_id": 32508, "supplement_id": 1459, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if Poly-\u03b3-Glutamic Acid (\u03b3-PGA) enhances the therapeutic effect of an HPV16 E7-expressing Lactobacillus casei vaccine in a murine cancer model.", "results_summary": "\u03b3-PGA co-treatment with L. casei-E7 significantly suppressed tumor growth and increased survival rates in mice, enhancing innate immune responses and NK cell activation but not E7-specific CD8+ T cell activity. No in vitro cytotoxicity was observed.", "population_specificity": "TC-1 murine cancer model (mice).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:10.354405+00:00"}
{"study_id": 32507, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of endo-type (pgdS) and exo-type (ggt) \u03b3-PGA hydrolases in \u03b3-PGA production and properties in Bacillus licheniformis strains.", "results_summary": "Deletion of pgdS strongly inhibited \u03b3-PGA production, while deletion of ggt increased \u03b3-PGA production to 39 g/L and maintained larger molecular mass. The \u0394ggt strain's \u03b3-PGA showed greater flocculation efficiency in sewage sludge compared to the original strain.", "population_specificity": "Bacillus licheniformis strains RK14 and RK14-46.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:10.829433+00:00"}
{"study_id": 32505, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the performance of poly-\u03b3-glutamic acid (\u03b3-PGA) in removing heavy metals (Cu, Zn, Ni, Cr) from contaminated soil through soil washing.", "results_summary": "Under optimal conditions (\u03b3-PGA 3.5%, liquid/soil ratio 15/1, washing time 60 min, rotational speed 100 rpm), \u03b3-PGA removed up to 50.7% of Cu in lab tests and 54.3% in on-site treatment, improving to 74.3% after three washes. The treatment did not significantly alter soil bacterial numbers, suggesting environmental safety.", "population_specificity": "Contaminated farmland soil with heavy metals (Cu, Zn, Ni, Cr).", "effective_dosage": "3.5% \u03b3-PGA concentration, liquid/soil ratio 15/1.", "study_duration": "60 minutes per wash (up to 3 washes).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:11.462371+00:00"}
{"study_id": 32506, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop a novel method for agricultural waste treatment and upscale solid-state fermentation processes to produce Poly-\u03b3-Glutamic Acid (\u03b3-PGA) using Bacillus amyloliquefaciens JX-6.", "results_summary": "The study found that \u03b3-PGA production was higher in a 50 L bioreactor (116.88 \u00b1 5.05 g/kg) compared to a 150 L bioreactor (102.48 \u00b1 3.30 g/kg), indicating reduced production with scale-up. The fermentation parameters and bacterial communities varied with bioreactor capacity, affecting substrate utilization and \u03b3-PGA yield.", "population_specificity": "Agricultural waste (corn stalk and soybean meal) in a fermentation system.", "effective_dosage": "Not specified (production measured in g/kg of substrate).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:12.496428+00:00"}
{"study_id": 32509, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of Ch/\u03b3-PGA nanoparticles as vehicles for IFN-\u03b3 and their ability to modulate immune cell phenotypes.", "results_summary": "The study found that Ch/\u03b3-PGA nanoparticles enhanced immunostimulatory profiles in dendritic cells and macrophages, increased pro-inflammatory cytokine secretion, and hampered colorectal cancer cell invasion, with IFN-\u03b3 incorporation further potentiating these effects.", "population_specificity": "In vitro study involving immune cells (dendritic cells, macrophages) and colorectal cancer cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:12.553078+00:00"}
{"study_id": 32498, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of Poly-\u03b3-Glutamic Acid (\u03b3-PGA) and \u03b3-PGA super absorbent polymer (SAP) on sandy loam soil hydro-physical properties, including water infiltration, total available water, and retention time.", "results_summary": "Both \u03b3-PGA and \u03b3-PGA SAP reduced cumulative water infiltration in sandy loam soil. \u03b3-PGA at 0.10% addition showed the highest total available water, while \u03b3-PGA SAP significantly increased water retention, with TM3 (0.15% addition) having the highest absorption. Retention time increased with higher \u03b3-PGA SAP concentrations.", "population_specificity": "Sandy loam soil (laboratory conditions)", "effective_dosage": "0.05%, 0.10%, 0.15%, and 0.20% soil mass ratios", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:14.153482+00:00"}
{"study_id": 32510, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to enhance \u03b3-PGA production in Bacillus amyloliquefaciens LL3 by genetically engineering its glutamate metabolism-relevant networks.", "results_summary": "The study successfully increased \u03b3-PGA production through chromosomal engineering, promoter insertion, NADPH level regulation, and metabolic evolution, achieving a 2.05-fold improvement (7.53 g l-1) compared to the original strain.", "population_specificity": "Bacillus amyloliquefaciens LL3 (microbial strain)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:15.591365+00:00"}
{"study_id": 32513, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the catalytic and antibacterial properties of a nanocomposite containing Poly-\u03b3-Glutamic Acid-derived amorphous carbon nitride films.", "results_summary": "The nanocomposite demonstrated effective degradation of methyl orange and strong antibacterial activity against E. coli and S. aureus, maintaining efficacy after multiple recycles.", "population_specificity": "Not applicable (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:17.694326+00:00"}
{"study_id": 32511, "supplement_id": 1459, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of Poly-\u03b3-Glutamic Acid (\u03b3-PGA) as a nanomaterial for delivering hydrophobic anticancer drugs, specifically paclitaxel (PTX), while minimizing side effects.", "results_summary": "The study found that PDA-coated \u03b3-PGA micelles (PDA/AM/P) enabled a 3.6-fold higher PTX dose delivery compared to surfactant-solubilized PTX, completely ablated tumors, and prevented recurrence with no reported side effects. Near-infrared irradiation enhanced the anticancer effect, demonstrating synergistic photothermal therapy.", "population_specificity": "Cancer cells and in vivo tumor models (specific type not detailed in abstract).", "effective_dosage": "Not specified (only relative dose comparison mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:19.468780+00:00"}
{"study_id": 32514, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop a poly(\u03b3-glutamic acid)-based electrospun photocrosslinkable hydrogel fibrous scaffold incorporated with ginsenoside Rg3 (GS-Rg3) for accelerated wound healing and scarless skin regeneration.", "results_summary": "The scaffold promoted fibroblast growth and organized basement formation in early-stage wound healing, while sustained GS-Rg3 release in late stages reduced angiogenesis and collagen accumulation, leading to scarless wound healing in vivo.", "population_specificity": "In vivo (animal model, specific species not mentioned)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:19.509794+00:00"}
{"study_id": 32516, "supplement_id": 1459, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the mechanical properties, drug release behavior, and biocompatibility of HA/\u03b3-PGA hydrogels as injectable drug carriers for load-bearing tissue applications.", "results_summary": "The HA/\u03b3-PGA hydrogels demonstrated excellent anti-compression ability, shape recovery, and tunable mechanical properties. They also showed weak burst release, sustained drug release behavior, and superior biocompatibility.", "population_specificity": "Not specified (in vitro or preclinical study implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:20.221817+00:00"}
{"study_id": 32517, "supplement_id": 1459, "safety_score": "85", "efficacy_score": 78, "quality_score": 82, "study_goal": "The researchers aimed to develop a biodegradable polymer (\u03b3-PGA)-based nanoparticle system for safe and effective anticancer therapy by encapsulating adenovirus to reduce immune response and enhance targeted delivery.", "results_summary": "The study successfully encapsulated adenovirus into \u03b3-PGA-CH nanoparticles with 92% efficiency and reduced antibody detection to 3.1%, demonstrating potential for controlled release and targeted cancer therapy. The polymer's biocompatibility and low toxicity were highlighted.", "population_specificity": "In vitro study (no human or animal subjects specified).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:20.491874+00:00"}
{"study_id": 32515, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Poly-\u03b3-Glutamic Acid (\u03b3-PGA) from fermented soybeans could improve insulin sensitivity, insulin secretion, and neuronal cell health, potentially benefiting type 2 diabetes and Alzheimer's disease.", "results_summary": "The study found that \u03b3-PGA from specific Bacillus strains (BA730 and BA731) improved insulin-stimulated glucose uptake, reduced triglyceride accumulation, enhanced neuronal cell survival, and modulated markers related to diabetes and Alzheimer's disease. BA731 showed stronger effects on insulin sensitivity, while BA730 increased PPAR-\u03b3 activity.", "population_specificity": "3T3-L1 adipocytes, min6 cells, PC12 neuronal cells (in vitro study).", "effective_dosage": "High-dosage treatments mentioned, but exact amounts not specified.", "study_duration": "Not explicitly stated.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:22.116415+00:00"}
{"study_id": 32518, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 82, "study_goal": "The researchers aimed to investigate the effect of glucose and glutamic acid on the expression of PGA operon genes in Bacillus subtilis Natto3 and their role in PGA production.", "results_summary": "The study found up-regulation of ywsC and ywtA genes and down-regulation of ywtB and ywtC genes in both treatment groups, suggesting the critical role of ywsC and ywtA in PGA production. The expression pattern of these genes was unique and previously unreported.", "population_specificity": "Bacillus subtilis Natto3 (bacterial strain)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:23.134968+00:00"}
{"study_id": 32519, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the functional restoration of needle puncture-injured intervertebral discs using an injectable hydrogel composed of gelatin and poly-\u03b3-glutamic acid (\u03b3-PGA) crosslinked with EDC.", "results_summary": "The GP/E(10:1) hydrogel group showed the highest leakage and saturate pressure, comparable to intact discs, indicating effective restoration of disc integrity. Other hydrogel formulations were less effective.", "population_specificity": "Bovine motion segments (in vitro study).", "effective_dosage": "Not specified (different polymer solutions and EDC concentrations used, including 10:1 and 40:1 ratios).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:24.411107+00:00"}
{"study_id": 32522, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how phosphorylation modifies the physicochemical properties of Poly-\u03b3-Glutamic Acid (PGA) and its effects on viscosity and molecular structure.", "results_summary": "Phosphorylation of PGA altered its molecular weight distribution and viscosity, with low phosphorylation increasing viscosity and high phosphorylation causing aggregation. Heat treatment induced a novel collagen-like helix structure, demonstrating that phosphorylation diversifies PGA's properties.", "population_specificity": "Bacillus subtilis (natto) culture medium (in vitro study).", "effective_dosage": "Not specified (dependent on phosphorylating agent amounts).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:28.309108+00:00"}
{"study_id": 32520, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Poly-\u03b3-Glutamic Acid (PGA) could enhance the stability and dechlorination performance of palladium-doped zero-valent iron nanoparticles (Fe-Pd NPs).", "results_summary": "Fe-Pd@PGA NPs demonstrated high stability, uniform distribution, and significantly improved dechlorination activity\u2014over ten times higher than bare Fe-Pd NPs\u2014even in weakly alkaline conditions and in the presence of certain anions like Cl- and H2PO4-. PGA was identified as a crucial stabilizer and promoter for Fe-Pd NPs.", "population_specificity": "Not applicable (in vitro study using nanoparticles and p-CP as a model compound).", "effective_dosage": "Fe to p-CP ratio of 100 (specific PGA dosage not detailed).", "study_duration": "Not specified.", "interactions": "HPO42- and HCO3- ions slightly reduced dechlorination activity; no other interactions mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:28.422026+00:00"}
{"study_id": 32521, "supplement_id": 1459, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether a novel nano-drug carrier system using poly-\u03b3-glutamic acid (PAT) could reduce the toxicity of triptolide (TP) while maintaining its therapeutic efficacy in rheumatoid arthritis.", "results_summary": "PAT reduced toxicity and apoptosis in cells, decreased cytokine expression in macrophages, and showed fewer side effects in vivo while maintaining therapeutic benefits similar to free TP, including reduced inflammation, cartilage loss, and bone erosion.", "population_specificity": "Tumor necrosis factor \u03b1 transgenic mice (in vivo) and RAW264.7 cells (in vitro).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:28.430974+00:00"}
{"study_id": 32523, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of CET MAb-DOCT-\u03b3-PGA nanoparticles in targeting EGFR-overexpressing gastric cancer cells and compare their efficacy to nontargeted nanoparticles and free DOCT.", "results_summary": "Targeted nanoparticles showed increased uptake and enhanced cytotoxicity in EGFR-positive MKN-28 cells, superior pharmacokinetics in mice, and efficient tumor growth arrest in xenograft models compared to nontargeted nanoparticles and free DOCT.", "population_specificity": "EGFR-overexpressing gastric cancer cells (MKN-28) and Swiss albino mice with MKN-28-based xenografts.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:29.308621+00:00"}
{"study_id": 32524, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Chitosan/Poly-\u03b3-Glutamic Acid nanoparticles could modulate the inflammatory profile of antigen-presenting cells (macrophages and dendritic cells) and inhibit their ability to promote cancer cell invasion.", "results_summary": "Ch/\u03b3-PGA NPs induced an immunostimulatory phenotype in dendritic cells and macrophages, enhancing pro-inflammatory cytokine secretion and co-stimulatory molecule expression, which promoted T cell activation and partially inhibited colorectal cancer cell invasion.", "population_specificity": "Human antigen-presenting cells (macrophages and dendritic cells) in the context of colorectal cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:29.378927+00:00"}
{"study_id": 32525, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the production of Poly-\u03b3-Glutamic Acid (\u03b3-PGA) by different Bacillus licheniformis strains under varying medium compositions, using online volumetric power input and oxygen transfer rate (OTR) measurements.", "results_summary": "The study found that higher citric acid concentration and trace element addition positively influenced \u03b3-PGA production. Online power input and OTR measurements effectively monitored \u03b3-PGA formation and strain respiration activity, with the derived online viscosity signal validated against offline measurements.", "population_specificity": "Bacillus licheniformis strains in laboratory fermentation conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:30.813484+00:00"}
{"study_id": 32527, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the chemical and physicochemical properties of phosphorylated Poly-\u03b3-Glutamic Acid (PGA) derivatives and their potential relevance to protein aggregation diseases like Alzheimer's.", "results_summary": "The study found that phosphorylated PGA derivatives exhibited unique hydration and viscosity properties, with one derivative (J-5) showing protein aggregation behavior similar to \u03b2-sheet cross-linking, which is associated with diseases like Alzheimer's. The J-5 derivative also displayed high thioflavin T fluorescence intensity without heat treatment, indicating aggregation potential.", "population_specificity": "Not specified (in vitro study using Bacillus subtilis (natto) culture medium).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:33.735198+00:00"}
{"study_id": 32530, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop a \u03b3-PGA-based GGT-targeting and surface camouflage strategy to improve gene delivery and cancer therapy by enhancing serum tolerance and tumor-specific uptake.", "results_summary": "The \u03b3-PGA/PEI/pDNA nanoparticles showed improved serum tolerance and targeted tumor cells via GGT-mediated endocytosis, effectively inhibiting tumor cell proliferation and suppressing tumor growth in mice. The strategy demonstrated potential for enhanced gene delivery and cancer therapy.", "population_specificity": "Mice bearing cervical tumors.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:37.000171+00:00"}
{"study_id": 32531, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether foliar application of poly-\u03b3-glutamic acid (\u03b3-PGA) could alleviate salt stress-induced damage in wheat seedlings.", "results_summary": "\u03b3-PGA application significantly increased plant height, weight, and antioxidant enzyme activity (superoxide dismutase, peroxidase, catalase) while reducing Na+ accumulation and increasing K+ levels in wheat leaves under salt stress. The results suggest \u03b3-PGA improves salt tolerance by mitigating ionic imbalances and enhancing antioxidant capacity.", "population_specificity": "Wheat seedlings", "effective_dosage": "400 mg/L (foliar application)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:37.769919+00:00"}
{"study_id": 32529, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to characterize the glutamate dehydrogenase (RocG) in glutamic acid synthesis from B. licheniformis to understand its role in enhancing \u03b3-PGA production.", "results_summary": "The study found that deleting the rocG gene in B. licheniformis reduced intracellular glutamic acid concentration by 76.3% and \u03b3-PGA yield by 45.3%, demonstrating RocG's critical role in glutamic acid synthesis and \u03b3-PGA production. In vitro assays confirmed RocG's higher affinity for 2-oxoglutarate and its predominant role in glutamate synthesis over degradation.", "population_specificity": "Bacillus licheniformis (bacterial strain)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:39.193412+00:00"}
{"study_id": 32532, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the potential of Poly-\u03b3-Glutamic Acid (\u03b3-PGA) modified with cholesterol as a pH-responsive drug delivery carrier for antitumor drugs.", "results_summary": "The study found that \u03b3-PGA/Chol nanoparticles formed raspberry-like hydrogel particles (RBHPs) with controlled drug release properties, effective cellular uptake in human cervical cancer cells (HeLa), and pH-dependent membrane-disrupting capabilities for cytosolic drug delivery. The cytotoxic effect was concentration- and time-dependent.", "population_specificity": "Human cervical cancer cells (HeLa) in vitro and ex vivo.", "effective_dosage": "Approximately 63.9 \u03bcg Dox/mg of RBHPs.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:39.197049+00:00"}
{"study_id": 32533, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-inflammatory and regenerative effects of intradiscal injection of Chitosan/Poly-\u03b3-Glutamic Acid nanoparticles loaded with diclofenac in a degenerated intervertebral disc model.", "results_summary": "The study found that the nanoparticles reduced inflammation (down-regulating IL-6, IL-8, MMP1, and MMP3, and decreasing PGE2 production) while promoting extracellular matrix production (up-regulating collagen type II and aggrecan) in a pro-inflammatory/degenerative disc model.", "population_specificity": "Bovine intervertebral disc organ culture under pro-inflammatory/degenerative conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:40.020162+00:00"}
{"study_id": 32528, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop a cost-effective method for producing poly-\u03b3-glutamic acid (\u03b3-PGA) using a novel strain of Bacillus amyloliquefaciens NX-2S via non-food fermentation.", "results_summary": "The study found that inulin addition upregulated key genes involved in \u03b3-PGA production, and the novel strain produced 6.85\u00b10.22g/L of \u03b3-PGA without exogenous glutamate, which increased to 39.4\u00b10.38g/L with exogenous glutamate. The method demonstrated high productivity (0.43\u00b10.05g/L/h) in batch fermentation.", "population_specificity": "Microbial fermentation (Bacillus amyloliquefaciens NX-2S)", "effective_dosage": "Not specified (fermentation yield: 6.85\u00b10.22g/L without glutamate, 39.4\u00b10.38g/L with glutamate)", "study_duration": "Not specified (batch fermentation)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:40.775891+00:00"}
{"study_id": 32526, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if cRGDfK peptide-conjugated poly(\u03b3-glutamic acid)-phenylalanine nanoparticles could enhance the therapeutic efficacy of camptothecin against glioblastoma multiforme.", "results_summary": "The nanoparticles (RCPN) showed dose- and time-dependent cytotoxicity, increased apoptosis, higher reactive oxygen species generation, and inhibited cell migration in U87MG glioblastoma cells compared to native CPT or unconjugated nanoparticles.", "population_specificity": "U87MG human glioblastoma cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:41.516912+00:00"}
{"study_id": 32534, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of PVA-based electrospun hydrogel nanofibers, including PVAPGA, as scaffolds for cell culture and tissue engineering applications.", "results_summary": "The study found that 3T3 fibroblast cells exhibited similar viability on all electrospun fibers, with cell viability increasing over time. Cell attachment, communication, and ECM production were observed, suggesting PVAPGA nanofibers are suitable for tissue engineering scaffolds.", "population_specificity": "3T3 mouse fibroblast cells", "effective_dosage": "Not specified", "study_duration": "Observations were made at 1, 3, and 7 days post-seeding", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:42.245887+00:00"}
{"study_id": 32535, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Poly-\u03b3-Glutamic Acid (\u03b3-PGA) could mitigate cold stress effects on rape seedlings by enhancing physiological responses and cold resistance mechanisms.", "results_summary": "\u03b3-PGA reduced malondialdehyde content by 33.4%, increased proline content by 62.5%, and enhanced antioxidant enzyme activities under cold stress. It also improved fresh weight (24.5%) and chlorophyll content (50.9%) in rape seedlings, suggesting mitigation of cold-induced growth inhibition.", "population_specificity": "Rape seedlings (Brassica napus) grown hydroponically.", "effective_dosage": "Not specified", "study_duration": "144 hours (6 days)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:45.953625+00:00"}
{"study_id": 32536, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine if immobilizing cross-linked poly-\u03b3-glutamic acid (\u03b3-PGA) on a Co-Cr alloy surface could enhance its bioactivity and induce apatite formation in simulated body fluid.", "results_summary": "The study found that \u03b3-PGA immobilization made the Co-Cr alloy surface highly hydrophobic and facilitated the formation of a low-crystalline apatite layer when treated with CaCl2 and soaked in simulated body fluid, indicating improved bioactivity.", "population_specificity": "Not specified (in vitro study on Co-Cr alloy)", "effective_dosage": "CaCl2 at 0.5 M or more", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:46.730849+00:00"}
{"study_id": 32537, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of DOX-loaded micelles based on \u03b3-PGA-g-PLLA for improving the solubility and bioavailability of hydrophobic anti-cancer drugs, particularly in tumor therapy.", "results_summary": "The study found that DOX-loaded \u03b3-PGA-g-PLLA micelles exhibited faster drug release in acidic conditions, which is advantageous for tumor therapy, and cellular uptake was mediated by GGT.", "population_specificity": "Not specified (in vitro or preclinical study implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:46.947675+00:00"}
{"study_id": 32540, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-cancer effects of Poly-\u03b3-Glutamic Acid (PGA), particularly its ability to promote apoptosis in colorectal cancer cells and modulate signaling pathways.", "results_summary": "PGA inhibited cancer cell proliferation, induced apoptosis (evidenced by DNA fragmentation and PARP/caspase 3 cleavage), reduced expression of cancer-related genes (COX-2 and iNOS), and activated AMPK in HT-29 colorectal cancer cells.", "population_specificity": "HT-29 human colorectal cancer cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:48.874013+00:00"}
{"study_id": 32541, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the in vivo efficacy of ultra-high molecular weight poly-\u03b3-glutamic acid (UHMW \u03b3-PGA) for wound healing.", "results_summary": "UHMW \u03b3-PGA significantly reduced wound area by day 8 and promoted epidermal regeneration, collagen pigmentation, and blood vessel regeneration by day 16 compared to controls. Increased levels of transforming growth factor-beta and \u03b2-catenin were also observed in treated groups.", "population_specificity": "Animal model (specific species not mentioned in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "16 days post-wounding.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:50.158874+00:00"}
{"study_id": 32538, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 60, "study_goal": "The researchers aimed to investigate the effect of \u03b3-PGA on the treatment of vaginal intraepithelial neoplasia (VAIN), particularly its impact on cytological regression and HPV viral load reduction.", "results_summary": "\u03b3-PGA showed cytological regression in 41.7% and 50% of patients at the first and second post-treatment visits, respectively, and an overall HPV load response rate of 66.7% at the first follow-up, though statistical significance was marginal (p = 0.084). The results suggest \u03b3-PGA may be a promising treatment for primary or persistent VAIN.", "population_specificity": "12 high-risk HPV-positive patients with biopsy-proven VAIN (VAIN1, VAIN2, or VAIN3).", "effective_dosage": "Not specified", "study_duration": "Mean of 4.5 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:50.710020+00:00"}
{"study_id": 32542, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the potential of low molecular weight \u03b3-PGA as an adjuvant for cancer vaccines by assessing its effects on dendritic cell functions and adaptive immunity in a mouse tumor model.", "results_summary": "\u03b3-PGA enhanced dendritic cell-mediated functions (activation, maturation, antigen uptake, migration, and lymphocyte priming) in a dose-dependent manner, with TLR4 stimulation as a key mechanism. In vivo, \u03b3-PGA significantly boosted both humoral and cell-mediated immunity, inhibited tumor growth, and induced long-lasting immune memory.", "population_specificity": "Mice (EG7-OVA tumor model)", "effective_dosage": "Not specified", "study_duration": "71 days (including rechallenge)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:51.677899+00:00"}
{"study_id": 32539, "supplement_id": 1459, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine if amphiphilic poly(\u03b3-glutamic acid) (\u03b3-PGA-AAE) nanoparticles could serve as safe and effective adjuvants to control the balance and induction level of cellular and humoral immunities in vaccines.", "results_summary": "The study found that \u03b3-PGA-AAE nanoparticles could encapsulate antigens like ovalbumin (OVA) and control the type and induction level of immune responses\u2014cellular immunity was dominant when OVA was encapsulated, while humoral immunity was dominant when OVA was mixed with NPs. The results suggest \u03b3-PGA-AAE NPs are promising adjuvants for vaccine design.", "population_specificity": "Not specified (likely preclinical or in vitro/in vivo models, as human data is not mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:52.578981+00:00"}
{"study_id": 32543, "supplement_id": 1459, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the targeting efficiency and cytotoxicity of a Poly-\u03b3-Glutamic Acid-based drug delivery system (PAMCN) targeting APN/CD13 for antiangiogenic chemotherapy.", "results_summary": "PAMCN demonstrated enhanced cytotoxicity and targeting efficiency, reducing IC50 values for cisplatin in HUVEC cells and inhibiting tube formation in vitro. In vivo, PAMCN showed no toxicity in KM mice and reduced hepatic and renal toxicity compared to free cisplatin.", "population_specificity": "Human umbilical vein endothelial cells (HUVEC) and KM mice.", "effective_dosage": "Not specified (cisplatin loading content was 36 \u00b1 5%).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:55.380954+00:00"}
{"study_id": 32545, "supplement_id": 1459, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of transferrin-modified \u03b3-PGA-MAL-PLA-DPPE nanoparticles for targeted delivery of paclitaxel to tumor cells.", "results_summary": "The nanoparticles demonstrated high encapsulation efficiency, pH-dependent drug release, and enhanced cellular uptake in transferrin receptor-overexpressing cancer cells. Tf modification improved the cytotoxic activity of paclitaxel against targeted tumor cells.", "population_specificity": "Nasopharyngeal carcinoma (C666-1) cells and human cervical carcinoma (Hela) cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:55.814087+00:00"}
{"study_id": 32544, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether ultra-high molecular weight poly-\u03b3-glutamic acid (UHMW \u03b3-PGA) inhibits 5-alpha reductase activity and promotes hair growth in telogenic mice.", "results_summary": "UHMW \u03b3-PGA inhibited 5-alpha reductase activity in vitro and promoted hair growth in telogenic C57BL/6 mice, inducing the anagen phase earlier than the control group. The treated group showed hair growth on over 50% of shaved skin, with more hair follicles observed compared to controls.", "population_specificity": "Telogenic C57BL/6 mice", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:56.542338+00:00"}
{"study_id": 32546, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the synergistic anti-tumor effects of paclitaxel and imiquimod dispersed in Poly-\u03b3-Glutamic Acid (\u03b3-PGA) and its potential to enhance immune response and tumor inhibition.", "results_summary": "The study found that \u03b3-PGA-stabilized paclitaxel and imiquimod demonstrated significant tumor-killing effects in vitro and in vivo, enhanced dendritic cell proliferation and activation, and induced systemic anti-tumor memory response, leading to 70% survival in treated mice.", "population_specificity": "Mouse melanoma tumor model (in vivo) and various tumor cell lines (in vitro).", "effective_dosage": "Not specified", "study_duration": "More than 6 months (stability testing); tumor growth monitored until day 41.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:58.462450+00:00"}
{"study_id": 32547, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether incorporating Poly-\u03b3-Glutamic Acid (\u03b3PGA) into chitosan (CS) complexes could enhance gene transfection efficiency and explore its potential for DNA/siRNA delivery and photodynamic therapy.", "results_summary": "The study found that \u03b3PGA improved the transfection efficiency of CS complexes by reducing electrostatic interactions, enabling effective gene release. It also demonstrated potential for delivering dual PEGylated siRNAs and expressing membrane-targeted KillerRed for photodynamic therapy.", "population_specificity": "Not specified (likely in vitro or preclinical models).", "effective_dosage": "Not mentioned.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:59.563087+00:00"}
{"study_id": 32548, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Poly-\u03b3-Glutamic Acid (\u03b3PGA) could modulate the development of atopic dermatitis (AD) in a Th2-biased immune disease model.", "results_summary": "Oral administration of \u03b3PGA significantly reduced AD development in NC mice by promoting Th1/Th17 cell differentiation, reducing Th2 responses (e.g., serum IgE), and altering allergic reaction components like mast cells and eosinophils. The study suggests \u03b3PGA may have therapeutic potential for human AD.", "population_specificity": "NC/Nga (NC) mice, a model for atopic dermatitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:00.000867+00:00"}
{"study_id": 32549, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to eliminate the endogenous plasmid in Bacillus amyloliquefaciens LL3 to study its function and impact on \u03b3-PGA production.", "results_summary": "Plasmid-cured strains showed a 6% increase in \u03b3-PGA production (4.159 g/l vs. 3.918 g/l in control) and improved early-stage cell growth, with no change in molecular weight or sporulation efficiency.", "population_specificity": "Bacillus amyloliquefaciens LL3 bacterial strain.", "effective_dosage": "Not specified.", "study_duration": "Incubation at 30\u00b0C for 30 generations.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:00.367462+00:00"}
{"study_id": 32550, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the effects of green tea extract (GTE) alone versus GTE coadministered with poly-\u03b3-glutamic acid (\u03b3-PGA) on obesity and type 2 diabetes mellitus (T2DM) prevention.", "results_summary": "In db/db mice, GTE+\u03b3-PGA significantly reduced weight gain, body fat, glucose intolerance, fatty liver incidence, and pancreatic islet size compared to controls, while GTE or \u03b3-PGA alone showed no significant effects.", "population_specificity": "db/db mice (a model for obesity-induced T2DM) and age-matched nondiabetic mice.", "effective_dosage": "GTE (1%), \u03b3-PGA (0.1%), or GTE+\u03b3-PGA (1%:0.1%) in diet.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:02.755637+00:00"}
{"study_id": 32551, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Poly-\u03b3-Glutamic Acid (\u03b3-PGA) on angiogenesis and inflammation in a mouse model of colitis.", "results_summary": "\u03b3-PGA significantly reduced weight loss, disease activity index, colon shortening, histopathological injury, blood vessel densities, and expression of VEGF-A and VEGFR2, while also decreasing leukocyte recruitment to the inflamed colon.", "population_specificity": "Male C57BL/6 mice with dextran sulfate sodium (DSS)-induced colitis.", "effective_dosage": "50 mg/kg and 200 mg/kg body weight per day.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:04.114334+00:00"}
{"study_id": 32553, "supplement_id": 1459, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to develop and evaluate a novel drug delivery system using Poly-\u03b3-Glutamic Acid (gamma-PGA) nanogels for controlled release of the anticancer drug doxorubicin (Dox).", "results_summary": "The study found that gamma-PGA nanogels effectively loaded and released Dox in a controlled manner, particularly in the presence of reducing agents like glutathione (GSH). The nanogels demonstrated significant cellular uptake and cytotoxic effects in breast cancer cells (MCF-7), dependent on concentration and treatment time.", "population_specificity": "Breast cancer cells (MCF-7) in vitro.", "effective_dosage": "Approximately 38.7 \u00b5g Dox per mg of gamma-PGA nanogel.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:05.881400+00:00"}
{"study_id": 32554, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop and evaluate Poly-\u03b3-Glutamic Acid nanoparticles as an oral drug delivery system for the anticancer drug pixantrone.", "results_summary": "The study found that Poly-\u03b3-Glutamic Acid formed pH-dependent nanoparticles with pixantrone, demonstrated efficient cellular uptake, and enhanced drug efficacy in vitro. The nanoparticle size could be controlled by adjusting the solution volume ratio of the components.", "population_specificity": "In vitro study (no human or animal subjects specified).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:06.218708+00:00"}
{"study_id": 32552, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the co-production of \u03b3-PGA and fibrinolytic enzyme by Bacillus subtilis GXA-28 under sterilized and non-sterilized conditions using cane molasses and monosodium glutamate waste liquor.", "results_summary": "The study found that optimal conditions (3% total sugar from cane molasses, 2% glutamate from waste liquor, pH 7.0, 45\u00b0C) yielded high \u03b3-PGA (103.5 g/kg-substrates) and fibrinolytic activity (986 U/g-substrates) under non-sterilized conditions, with \u03b3-PGA yield being the highest reported in literature.", "population_specificity": "Not specified (laboratory study using Bacillus subtilis GXA-28 and substrates).", "effective_dosage": "Not applicable (study focused on production conditions, not human dosage).", "study_duration": "22-24 hours (production time under optimal conditions).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:07.498145+00:00"}
{"study_id": 32555, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of Poly-\u03b3-Glutamic Acid (PGA)-coated superparamagnetic iron oxide nanoparticles (SPIONs) as a chelator for removing heavy metals like lead and cadmium from solutions and simulated gastrointestinal fluid.", "results_summary": "PGA-SPIONs demonstrated rapid and efficient removal of lead and cadmium, with high removal capacities (147.71 mg/g for lead in SGIF and 31.13 mg/g for cadmium in deionized water). The coating improved dispersion and stability, with minimal interference from essential metals or ionic strength, except for reduced cadmium binding in certain conditions.", "population_specificity": "Not specified (in vitro study using metal solutions and simulated gastrointestinal fluid).", "effective_dosage": "Not specified (batch studies with varying pH and ionic strengths).", "study_duration": "Not specified (batch studies without explicit duration).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:09.754711+00:00"}
{"study_id": 32556, "supplement_id": 1459, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if linking an agonistic anti-CD40 monoclonal antibody to amphiphilic poly(\u03b3-glutamic acid) nanoparticles (\u03b3-PGA NPs) could enhance immunostimulatory effects while reducing systemic side effects.", "results_summary": "Anti-CD40-NPs improved CD40 agonist potency, increasing CD80/CD86 upregulation and IL-12 secretion in antigen-presenting cells, while reducing systemic cytokine levels (IL-6, IL-10, IL-12, TNF-\u03b1) in a bladder cancer model. The NPs also induced synergistic B-cell proliferation, likely due to enhanced CD40 multimerization.", "population_specificity": "Bladder cancer model (preclinical study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:10.835980+00:00"}
{"study_id": 32557, "supplement_id": 1459, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of poly-\u03b3-glutamic acid-coated magnetic nanoparticles (PG-M) for removing Pb2+ from water.", "results_summary": "PG-M effectively removed Pb2+ with an equilibrium adsorption capacity of 93.3 mg/g, optimal at pH 7.0 and 45 min contact time. The presence of humic acid enhanced removal below 5 mg/L but reduced it above this concentration, and PG-M was reusable after desorption with 0.1 mol/L HCl.", "population_specificity": "Water treatment applications (not human consumption).", "effective_dosage": "Not specified (adsorption capacity measured as 93.3 mg/g).", "study_duration": "Not specified (contact time was 45 min for optimal adsorption).", "interactions": "Reduced Pb2+ removal efficiency with increasing Ca2+ concentration.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:11.866104+00:00"}
{"study_id": 32558, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether coating chitosan/DNA complexes with poly(\u03b3-glutamic acid) (\u03b3-PGA) could enhance cellular uptake and transfection efficiency via a specific \u03b3-glutamyl transpeptidase (GGT)-mediated pathway.", "results_summary": "The study found that \u03b3-PGA coating made the complexes more compact, significantly enhanced their internalization and transfection efficiency, and identified GGT-mediated endocytosis as the uptake mechanism, with the N-terminal \u03b3-glutamyl unit of \u03b3-PGA playing a key role in this interaction.", "population_specificity": "Not specified (in vitro study, likely cell cultures)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:12.002037+00:00"}
{"study_id": 32559, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of high molecular weight poly-\u03b3-glutamic acid (hm gamma-PGA) on adiposity, lipid metabolism, and cholesterol levels in rats and humans under high-fat diet conditions.", "results_summary": "The study found that hm gamma-PGA reduced body weight gain, perirenal fat mass, serum total cholesterol, and LDL cholesterol while increasing HDL cholesterol in rats. In humans, it showed a tendency to lower total and LDL cholesterol levels.", "population_specificity": "Sprague-Dawley rats and 20 female human subjects.", "effective_dosage": "150 mg/day (human study).", "study_duration": "4 weeks (rats), 8 weeks (humans).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:13.858148+00:00"}
{"study_id": 32560, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of \u03b3-PGA on dendritic cells and its potential for treating Th2-mediated allergic asthma.", "results_summary": "\u03b3-PGA activated dendritic cells via TLR-4, promoting Th1 responses and reducing Th2-mediated allergic asthma symptoms, including airway hyperresponsiveness, inflammation, and IgE levels. These effects were abolished in TLR-4-defective mice.", "population_specificity": "Wild-type, TLR-2 deficient, and TLR-4-defective mice sensitized and challenged with ovalbumin (OVA).", "effective_dosage": "Not specified", "study_duration": "Repeated intranasal administration before and during the challenge period (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:15.108711+00:00"}
{"study_id": 32561, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of a Poly-\u03b3-Glutamic Acid-based block copolymer as a pH-controllable drug carrier for doxorubicin in treating human breast cancer cells (MCF-7/WT).", "results_summary": "The study found that the copolymer formed nano-sized micelles (90-200 nm) with pH-dependent properties, enhancing drug uptake in cancer cells while minimizing toxicity to healthy tissues. The micelles showed high drug loading efficiency (97.22%) and slow, controlled release of doxorubicin in acidic environments.", "population_specificity": "Wild type human breast cancer cells (MCF-7/WT).", "effective_dosage": "Critical micelle concentration range of 62-130 \u00b5g/mL.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:16.127994+00:00"}
{"study_id": 32562, "supplement_id": 1459, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential of \u03b3-PGA-Phe nanoparticles for treating retinal diseases by assessing their anti-inflammatory effects and cellular uptake in pathological conditions.", "results_summary": "The NPs were efficiently taken up by macrophages and microglia, showed prolonged retention, and demonstrated significant anti-inflammatory effects by suppressing TNF\u03b1 and MCP-1 expression, reducing microglial activation, and protecting retinal ganglion cells and photoreceptors in pathological retinas.", "population_specificity": "Rats (normal and pathological models of retinal disease)", "effective_dosage": "Not specified", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:16.198648+00:00"}
{"study_id": 32564, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the eye irritancy potential of gamma-PGA and its effects on corneal wound healing after alkali burns.", "results_summary": "Gamma-PGA promoted corneal wound healing compared to controls and showed similar efficacy to hyaluronic acid, likely due to anti-inflammatory effects and enhanced cell migration and proliferation.", "population_specificity": "30 white rabbits with alkali-burned corneas.", "effective_dosage": "0.1% 5000 kDa gamma-PGA.", "study_duration": "2 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:20.071271+00:00"}
{"study_id": 32817, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the efficacy and mechanism of Polygala tenuifolia glycoprotein (ZPG) in alleviating Alzheimer's disease (AD) symptoms and its potential clinical application.", "results_summary": "ZPG significantly improved cognitive deficits, reduced hippocampal pathology, normalized AD-related biomarkers, modulated gut microbiota and lipid metabolism, and exhibited neuroprotective effects in vitro by reducing apoptosis and oxidative stress.", "population_specificity": "Scopolamine hydrobromide-induced AD mice and A\u03b225-35-induced PC12 cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:20.439181+00:00"}
{"study_id": 32563, "supplement_id": 1459, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficiency of Poly-\u03b3-Glutamic Acid (\u03b3-PGA) as a chelating agent for lead-induced intoxication in mice and compare its effectiveness with meso-2,3-dimercaptosuccinic acid.", "results_summary": "\u03b3-PGA at 200 and 400 mg/kg reduced lead accumulation in the liver, heart, and testis but was less effective in the kidney and spleen. It also reduced oxidative stress markers (TBARs) in the kidney and brain, improved \u03b4-ALAD activity in blood, and lowered GPT and LDH activities in serum. Hematological changes included increased WBCs and HCT at 400 mg/kg, with slight declines in HGB, MCV, MCH, and MCHC.", "population_specificity": "Lead-intoxicated mice", "effective_dosage": "200 and 400 mg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:20.704153+00:00"}
{"study_id": 32565, "supplement_id": 1459, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the immune response and adjuvant activity of gamma-PGA nanoparticles in murine dendritic cells and their potential as a vaccine adjuvant.", "results_summary": "Gamma-PGA nanoparticles significantly upregulated proinflammatory chemokines, cytokines, and costimulatory molecules in dendritic cells, similar to LPS but distinct from unparticulate gamma-PGA. Immunization with gamma-PGA NPs carrying OVA induced strong antigen-specific CD8(+) T-cell responses and cytokine production, outperforming traditional adjuvants like aluminum hydroxide and complete Freund's adjuvant.", "population_specificity": "Murine bone marrow-derived dendritic cells and mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:20.975696+00:00"}
{"study_id": 32818, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the effects and mechanisms of Polygala Tenuifolia (PT) combined with Magnolia officinalis (MO) in treating cognitive impairment (CI) via the gut-brain axis.", "results_summary": "PT, MO, and their combination (PM) alleviated cognitive decline and neuropathological damage in D-gal-induced mice, reduced pro-inflammatory factors, increased antioxidant levels, and improved gut microbiota balance. PM also upregulated tight junction proteins, activated the cAMP pathway, and inhibited NF-\u03baB signaling.", "population_specificity": "D-gal-induced cognitive impairment mouse model.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:22.406722+00:00"}
{"study_id": 32819, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to characterize the PtCYP721A57 gene in Polygala tenuifolia and explore its role in the biosynthesis pathway of triterpenoid saponins, particularly tenuifolin.", "results_summary": "The study found that PtCYP721A57 expression was highest in the cortex of Polygala tenuifolia, correlating with tenuifolin content. Expression was influenced by hormones (ABA, CHT) and abiotic stress (drought, NaCl), peaking at 48 hours.", "population_specificity": "Not specified (plant-based study)", "effective_dosage": "Not applicable (gene expression study)", "study_duration": "Not applicable (gene expression study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:23.749078+00:00"}
{"study_id": 32821, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the intervention effects of saponin components from Polygala tenuifolia on dementia and explore their potential mechanisms.", "results_summary": "The saponin components of P. tenuifolia reduced \u03b2-amyloid accumulation, exhibited antioxidant and anti-inflammatory effects, regulated neurotransmitters, improved synaptic function, inhibited neuronal apoptosis, and modulated autophagy, suggesting potential benefits for dementia prevention and treatment.", "population_specificity": "Not specified (review of existing literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:24.284044+00:00"}
{"study_id": 32820, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the neuroprotective effects of Polygala tenuifolia polysaccharide (PTP) on Alzheimer's disease (AD) by examining its impact on endogenous metabolites and gut microbiota.", "results_summary": "PTP improved disruptions in endogenous metabolites and gut microbiota caused by AD, significantly altering 21 metabolites and enriching specific metabolic pathways. It also increased the relative abundance of beneficial gut bacteria, with changes in microbiota closely linked to metabolite shifts.", "population_specificity": "Not specified (likely animal or in vitro model based on abstract).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:24.654373+00:00"}
{"study_id": 32823, "supplement_id": 1460, "safety_score": "85", "efficacy_score": 78, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the clinical efficacy and safety of Polygala tenuifolia (PT) combined with Acorus tatarinowii (AT) in treating Alzheimer's disease (AD).", "results_summary": "The combination of PT and AT with conventional drugs improved cognitive and functional outcomes (MMSE, ADL, ADAS-cog) and clinical effectiveness without increasing adverse events compared to conventional drugs alone. However, the quality of evidence was rated as very low to low.", "population_specificity": "1,103 AD patients across 16 studies.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:29.172631+00:00"}
{"study_id": 32824, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the sleep-enhancing effect and mechanism of Polygala tenuifolia saponins (PTS) using insomnia-induced mice.", "results_summary": "YZ-I and YZ-II reduced immobility time, prolonged sleep duration, and increased concentrations of neurotransmitters (5-HT, NE) and inflammatory cytokines (IL-1\u03b2, TNF-\u03b1), suggesting sedative and hypnotic effects via serotonergic, GABAergic, and immune system modulation.", "population_specificity": "ICR mice with insomnia induced by p-chlorophenylalanine (PCPA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:29.392552+00:00"}
{"study_id": 32825, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the anti-Alzheimer's disease (AD) activity of the polysaccharide PTPS from Polygala tenuifolia in a mouse model and explore its molecular mechanism.", "results_summary": "PTPS improved spatial cognitive deficits in AD mice, reduced cellular damage in the hippocampus, maintained cholinergic system balance, and reduced A\u03b2 deposition. The anti-AD effect was linked to activation of ERK pathway-related proteins and enhanced synaptic plasticity.", "population_specificity": "Senescence-accelerated mouse/prone8 (SAMP8) model.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:29.443232+00:00"}
{"study_id": 32822, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify the active compounds in Polygala tenuifolia extract (EPT) and investigate its anti-inflammatory mechanism in treating acute lung injury (ALI) via TLR4/NF-\u03baB and NLRP3 signaling pathways.", "results_summary": "EPT reduced inflammatory factors and lung damage in ALI models, with polygalacic acid identified as a potential active ingredient. The extract demonstrated efficacy in both in vivo and in vitro models by modulating TLR4/NF-\u03baB and NLRP3 pathways.", "population_specificity": "Rats (in vivo) and THP-1 cells (in vitro).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:29.531883+00:00"}
{"study_id": 32826, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the pharmacological activity and mechanism of Polygala tenuifolia seed oil (PWSO) in attenuating hepatic lipid accumulation and inflammation in a mouse model of metabolic-associated fatty liver disease (MAFLD).", "results_summary": "PWSO reduced plasma and hepatic levels of total cholesterol (TC) and triglycerides (TG), ameliorated hepatic lipid accumulation, and improved inflammation by reducing IL-6 and TNF-\u03b1 levels. It inactivated SREBP1 and SREBP2 to attenuate lipogenesis and mitigated inflammatory responses via the NF-\u03baB pathway.", "population_specificity": "High-fat diet-induced MAFLD mouse model.", "effective_dosage": "14% PWSO in diet (replacing 14% of lard oil).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:32.277942+00:00"}
{"study_id": 32827, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify the bioactive components of Polygala Tenuifolia and evaluate its effects on neuroinflammation and cognitive improvement in Alzheimer's disease models.", "results_summary": "The study found that PTBP-1-3, a polysaccharide from Polygala Tenuifolia, reduced neuroinflammation by inhibiting microglia/astrocyte activation and lowering inflammatory markers (NO, TNF-\u03b1, IL-1\u03b2). It also improved learning and memory in Alzheimer's disease rats.", "population_specificity": "Alzheimer's disease rat models and lipopolysaccharide-activated BV2 microglia cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:32.322560+00:00"}
{"study_id": 32829, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify the active constituent of Polygala Tenuifolia that promotes hippocampal neurogenesis in a mouse model of Alzheimer's disease.", "results_summary": "DISS was found to be the most effective constituent in enhancing neural stem cell proliferation and neuronal differentiation, and it significantly improved cognitive deficits, neuronal injuries, and neurogenesis disorder in APP/PS1 transgenic mice.", "population_specificity": "Newborn C57BL/6 mice and adult APP/PS1 transgenic mice.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:32.464692+00:00"}
{"study_id": 32830, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the mechanism by which combining Polygala tenuifolia (PT) with Magnolia officinalis (MO) mitigates PT-induced gastrointestinal motility disorders.", "results_summary": "PT + MO (1:2) improved gastrointestinal function in mice with PT-induced motility disorders, primarily by regulating metabolites and pathways related to energy, amino acid, and fatty acid metabolism.", "population_specificity": "Mice with PT-induced gastrointestinal motility disorders.", "effective_dosage": "PT + MO (1:2 ratio)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:37.565999+00:00"}
{"study_id": 32832, "supplement_id": 1460, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine if Polygala Tenuifolia and ambroxol have synergistic effects in the blood and brain, and whether co-administration alters pharmacokinetics.", "results_summary": "The study found that Polygala Tenuifolia did not significantly alter the pharmacokinetics of ambroxol in rats, suggesting no pharmacokinetic interactions. Ambroxol penetrated the brain effectively, with a blood-to-brain distribution ratio of 30-34%.", "population_specificity": "Experimental rats", "effective_dosage": "1 g/kg, p.o. for 5 consecutive days", "study_duration": "5 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:37.832992+00:00"}
{"study_id": 32834, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective effects of Polygala tenuifolia Willd (APT) on scopolamine-induced learning and memory impairments in mice.", "results_summary": "APT ameliorated learning and memory impairment in scopolamine-induced mice by regulating cholinergic activity, increasing BDNF and IL-10 levels, reducing IL-1\u03b2 and AChE levels, and improving oxidative stress markers (SOD, GSH, MDA).", "population_specificity": "Scopolamine-induced mice (animal model).", "effective_dosage": "25, 50, and 100 mg/kg (oral administration).", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:38.105184+00:00"}
{"study_id": 32833, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the antidepressant effects of SY (containing Polygala Tenuifolia) in rats with CUMS-induced depressive-like behaviors and explore its mechanism related to hippocampal neurogenesis and the BDNF signaling pathway.", "results_summary": "SY demonstrated significant antidepressant effects in CUMS-exposed rats, enhancing hippocampal neurogenesis and activating the BDNF signaling pathway. These effects were blocked by the TrkB antagonist K252a, confirming the pathway's role in SY's mechanism.", "population_specificity": "Male Sprague-Dawley rats (180-200 g)", "effective_dosage": "67.5, 135, or 270 mg kg-1d-1 (oral administration)", "study_duration": "35 days (CUMS exposure) plus treatment until behavioral tests were completed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:39.297528+00:00"}
{"study_id": 32836, "supplement_id": 1460, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if RP02-1, a polysaccharide from Polygala tenuifolia, could inhibit pancreatic cancer cell growth by inducing apoptosis and suppressing autophagy.", "results_summary": "RP02-1 inhibited pancreatic cancer cell proliferation, migration, and colony formation, while inducing apoptosis and suppressing autophagy. It showed minimal toxicity in vitro and in vivo.", "population_specificity": "Pancreatic cancer cells (AsPC-1 and BxPC-3) and in vivo models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:40.387144+00:00"}
{"study_id": 32835, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether the aerial part of Polygala tenuifolia could improve learning and memory impairments induced by d-galactose/NaNO2 in mice.", "results_summary": "The aerial part of Polygala tenuifolia significantly improved learning and memory performance in mice, modulated cholinergic activity, reduced neuroinflammation and oxidative stress, and enhanced brain-derived neurotrophic factor signaling.", "population_specificity": "Mice with d-galactose/NaNO2-induced learning and memory impairment.", "effective_dosage": "25, 50, and 100 mg/kg administered orally.", "study_duration": "45 days (days 15-60 of the 60-day induction period).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:41.707432+00:00"}
{"study_id": 32837, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to study the sedative and hypnotic effects of Polygala Tenuifolia (PT) on aged insomnia rats and explore its underlying mechanisms.", "results_summary": "PT improved memory ability, prolonged sleep time, and modulated neurotransmitter levels (increased 5-HT and GABA, decreased Glu) in aged insomnia rats. Transcriptome analysis identified overlapping differentially expressed genes and suggested involvement in GABAergic signaling pathways.", "population_specificity": "Aged Sprague-Dawley male rats with induced insomnia.", "effective_dosage": "0.0875 g/kg (low), 0.175 g/kg (medium), 0.35 g/kg (high), administered via intragastric administration.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:43.188086+00:00"}
{"study_id": 32840, "supplement_id": 1460, "safety_score": "85", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety of Polygala tenuifolia root extract (BT-11) in adolescents aged 9 to 19 years.", "results_summary": "The study found no statistically significant differences in adverse reactions between the BT-11 and placebo groups, with all adverse events resolving without special treatment. Serious adverse reactions were unrelated to the test product.", "population_specificity": "Adolescents aged 9 to 19 years.", "effective_dosage": "300 mg daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:45.444612+00:00"}
{"study_id": 32838, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential beneficial effects of Tenuifolin (TEN) from Polygala tenuifolia on neuronal apoptosis and memory deficits in a mouse model of Alzheimer's disease.", "results_summary": "TEN treatment reversed spatial learning and memory deficits and reduced neuronal apoptosis in hippocampal areas in APP/PS1 transgenic AD mice. It also protected against A\u03b225-35-induced apoptosis, loss of mitochondria-membrane potential, and activation of caspases-3 and -9 in SH-SY5Y cells.", "population_specificity": "APP/PS1 transgenic Alzheimer's disease mice and SH-SY5Y cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:46.502971+00:00"}
{"study_id": 32839, "supplement_id": 1460, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the anticonvulsant and neuroprotective effects of novel compounds derived from Polygala tenuifolia and Acori Tatarinowii, particularly for treating refractory epilepsies.", "results_summary": "Compounds 68-70 demonstrated strong anticonvulsant activity, low neurotoxicity, and inhibitory effects on LDH enzymes, with 70 also acting as a positive allosteric modulator at GABAA receptors. These compounds showed promise for treating epilepsy, including refractory forms like Dravet syndrome.", "population_specificity": "Mouse models of epilepsy.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:46.985955+00:00"}
{"study_id": 32841, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify and characterize oxidosqualene cyclase (OSC) genes in Polygala tenuifolia seedlings induced by methyl jasmonate (MeJA) and assess their roles in triterpenoid biosynthesis.", "results_summary": "The study identified two full-length OSC genes (PtCAS1 and PtCAS2) in Polygala tenuifolia, which produce cycloartenol in yeast cells. Expression levels of these genes were highest in flowers and roots, and increased after MeJA treatment.", "population_specificity": "Polygala tenuifolia seedlings (plant-based study, no human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:48.197217+00:00"}
{"study_id": 32842, "supplement_id": 1460, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Polygala tenuifolia extract (PTE) exhibits anti-obesity effects and how it influences liver gene expression and gut microbiota.", "results_summary": "PTE inhibited lipid accumulation in adipocytes and reduced obesity-related markers in mice, including body weight, serum triglycerides, and liver steatosis. It also altered lipid metabolism genes, reduced inflammation, and improved gut microbiota balance.", "population_specificity": "High-fat diet-induced obese mice and 3T3-L1 adipocytes.", "effective_dosage": "Not specified in the abstract.", "study_duration": "5 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:48.807169+00:00"}
{"study_id": 32828, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the neuroprotective effects, mechanisms, and gastrointestinal toxicity of senegenin from Polygala Tenuifolia based on literature from the past two decades.", "results_summary": "The study found that senegenin exhibits pharmacological activities such as anti-oxidation, anti-inflammation, anti-apoptosis, and cognitive enhancement, with potential applications in treating neurodegenerative diseases, depression, and ischemia-reperfusion injury. However, it also highlighted gaps in systematic evidence for its pharmacological effects.", "population_specificity": "Not specified (literature review)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:51.414423+00:00"}
{"study_id": 32844, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify and isolate lactate dehydrogenase inhibitors from Polygala tenuifolia and evaluate their bioactivity using PC12 cells.", "results_summary": "Five compounds from Polygala tenuifolia were identified as lactate dehydrogenase inhibitors and isolated with high purity (93.29-97.65%). The study demonstrated that microwave-assisted extraction coupled with countercurrent chromatography is an efficient method for isolating these compounds, and the bioactivity was confirmed using PC12 cells.", "population_specificity": "In vitro (PC12 cells)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:51.617337+00:00"}
{"study_id": 32843, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to elucidate the structure of PTP (a polysaccharide from Polygala tenuifolia) and investigate its anticancer effects against SKOV3 xenograft tumor growth in mice, including the underlying mechanisms.", "results_summary": "PTP suppressed tumor growth in mice by inducing apoptosis and reduced serum VEGF and EGFR levels, as well as decreased transcript and protein levels of EGFR, VEGF, and CD34 in tumor-bearing mice. The study suggests PTP may be a potent chemopreventive agent for advanced ovarian cancer.", "population_specificity": "BALB/c mice with SKOV3 xenograft tumors.", "effective_dosage": "10, 20, and 40 mg/kg.", "study_duration": "Two weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:51.629513+00:00"}
{"study_id": 32847, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Polygala tenuifolia root extracts could be used to synthesize silver nanoparticles (AgNPs) with antibacterial properties.", "results_summary": "The study found that Polygala tenuifolia root extracts successfully synthesized AgNPs with strong antibacterial activity, particularly against Escherichia coli, and the method was eco-friendly, cost-effective, and scalable.", "population_specificity": "Not specified (in vitro study on bacterial cultures).", "effective_dosage": "70% aqueous ethanol extract (specific dosage not detailed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:54.856715+00:00"}
{"study_id": 32845, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the therapeutic potential of Polygala tenuifolia Willd. (PTW) in alleviating stress-exacerbated atopic dermatitis symptoms and its underlying mechanisms.", "results_summary": "PTW significantly reduced stress-exacerbated scratching behavior, skin inflammation, and serum markers like histamine and IgE. It also inhibited mast cell degranulation and modulated the PKA/p38 MAPK signaling pathway.", "population_specificity": "Mice with TMA-induced atopic dermatitis and human mast cell line-1 (HMC-1) cells.", "effective_dosage": "250 mg/kg PTW in mice; 500 \u00b5g/mL PTW extract in HMC-1 cells.", "study_duration": "6-9 days in mice; 30 min pre-treatment in HMC-1 cells.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:54.922150+00:00"}
{"study_id": 32846, "supplement_id": 1460, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the differences between Polygala tenuifolia root bark and root using HPLC fingerprint analysis and active component determination.", "results_summary": "The study found high similarity among 15 batches of Polygala tenuifolia samples, with significant differences in the contents of polygalaxanthone III and 3,6'-disinapoly sucrose between root bark and root. The results suggested that evaluating quality based on a single ingredient is not reasonable.", "population_specificity": "Not specified (in vitro analysis of plant samples).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:55.524236+00:00"}
{"study_id": 33109, "supplement_id": 1494, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of pyruvate and its metabolism in abiotic stress tolerance in Arabidopsis thaliana.", "results_summary": "The study found that pyruvate metabolism genes are regulated under abiotic stress, exogenous pyruvate enhances stress-responsive gene expression, and pyruvate exhibits cytoprotective effects comparable to other antioxidants.", "population_specificity": "Arabidopsis thaliana (model plant)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:02.582505+00:00"}
{"study_id": 33113, "supplement_id": 1494, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the novel application of mitapivat (a PK activator) in treating acquired PK deficiency, particularly in a patient with transfusion-dependent hemolytic anemia.", "results_summary": "Mitapivat therapy successfully liberated the patient from transfusions and significantly improved symptoms and quality of life, demonstrating its potential efficacy in acquired PK deficiency.", "population_specificity": "A patient with acquired PK deficiency due to clonal myeloid disorders, resulting in severe hemolytic anemia and transfusion dependence.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:03.120659+00:00"}
{"study_id": 33107, "supplement_id": 1494, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the pathogenesis, clinical characteristics, diagnosis, and treatment of Pyruvate Kinase Deficiency (PKD) to improve medical services for clinicians.", "results_summary": "The study highlights PKD as a rare disorder causing chronic hemolytic anemia and complications like iron overload and cardiopulmonary issues. Treatment involves individualized approaches, including red blood cell transfusions and pyruvate kinase activators.", "population_specificity": "Patients with Pyruvate Kinase Deficiency (PKD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:03.255709+00:00"}
{"study_id": 33111, "supplement_id": 1494, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether elevated mitochondrial superoxide reversibly impairs pyruvate oxidation and metabolic flexibility in skeletal muscle.", "results_summary": "The study found that elevated matrix superoxide reversibly impaired pyruvate-driven respiration, reducing metabolic flexibility. The pyruvate dehydrogenase kinase inhibitor dichloroacetate partially restored pyruvate-driven respiration, while the thiol reductant DTT did not.", "population_specificity": "Animal model (iSOD2 knockdown and control mice)", "effective_dosage": "Not specified", "study_duration": "Up to 24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:03.807538+00:00"}
